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Drug delivery has become a major research topic in the pharmaceutical field. A
drug delivery system (DDS) can be defined as device to introduce a therapeutic agent into
the body1.  It  is  composed  of  a  medium or  carrier  and  the  drug  to  be  administered  in  a
controlled manner. The main goal of all controlled release systems is to improve the
effectiveness of therapeutic agents in the body. For example, many drugs undergo
degradation before they reach the action site in the body (in oral delivery certain
medications are destroyed by the low pH in the stomach area). For this purpose drug
carriers must fulfill some requirements. They must be able to hold the drug molecule, to
release the drug under action of a stimulus (pH, temperature, dilution, electric or
magnetic field,…) and to disappear after the drug delivery (removal or degradation).
The earliest drug delivery systems appeared in the 1970s and were based on
polymers such as poly(lactic acid) (PLA)2. Since then the era of polymeric drug delivery
started in which a polymer matrix is used as a rate controlling device (Fig. 1.1)
Fig. 1.1: Polymeric drug delivery3
There are two very important aspects to drug delivery research: the drug carrier
and the control over the drug release rate.
Polymeric drug carriers can be broadly divided into two types4.  One  type
comprises non-degradable polymers which are preferred in removable medical devices.
The other type of carriers is made from biodegradable polymers which  are  favored  in
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permanent implants. These polymers dissolve when implanted and the release of
therapeutic agent is achieved during biodegradation or prior to degradation.
An important class of materials for use as polymer matrix is formed by cross-linked
polymer hydrogels. In the presence of water these polymers swell and build an open
polymer network filled with water whereby the drugs are released from the matrix by
diffusion5.
A drug delivery system can also be composed without the use of a polymer network.
Cyclodextrins (CDs) are most famous molecular carriers which are able to encapsulate
drug molecules in their internal hydrophobic cavity6,7,8.  CDs are very important in drug
delivery and are used as solubilizing agents to enhance drug solubility and bioavailability
as well as to protect drugs from enzymatic degradation and attack by various species.
The second important aspect in drug delivery is the wish to control in some way
the release of the drug from the carrier. Two types of control can be achieved: temporal
control and distribution control4.
The main goal in temporal control is the delivery of a therapeutic agent at a
predefined rate. That can be delivery over an extended period of time or a delivery at a
specified time. For example, for those drugs which are eliminated from the body very fast
it is desirable to achieve that the drug release rate from the carrier matches the drug
elimination rate. In that way the drug level in the body remains constant, which can bring
significant improvements in the drug therapy. This is known as sustained drug delivery.
In other cases it is desired to achieve a burst release of the drug at a required moment. For
that purpose an external stimulus has to be recognized by the delivery system that
stimulates the drug release (responsive drug delivery). This is the case for the delivery
of insulin where the stimulus is the growth of the blood sugar level.
The distribution control aims to deliver a drug to the desired location and to
maintain the necessary drug level at a targeted site. The targeted drug delivery is
desirable for situations where the therapeutic agent at other sites of the body can cause
big unwanted side effects, like for many chemotherapeutic drugs.
For  our  investigations  we have  chosen  as  a  drug  carrier  (the  matrix)  a  group of
hydrogels based on photopolymerized poly(ethylene glycol) diacrylate (PEGDA). By
varying the molar mass of the PEGDA oligomers, networks can be prepared with varying
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average molecular mesh sizes and chemical composition, which will affect the matrix
swelling, the drug-matrix interaction and consequently the drug diffusion and the drug
release rate. These polymers were made as thin films which opens their application also
as coating materials. In medicine it is of great importance to develop materials for the
coating of heart stents. Stents are cylindrically shaped devices which are inserted in a
segment of a blood vessel to keep it open and to allow free blood flow through it (Fig.
1.1).
          Fig. 1.1: A non-coated steel stent9
However, implantation of stents can cause many unwanted side effects such as
inflammation or thrombosis. To prevent this coated stents are being developed in which a
drug is released from the coating, the so-called drug eluting stents (Fig. 1.2).
Fig. 1.2: A polymer coated stent
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During insertion of a stent in a blood vessel the stent is subjected to mechanical forces
and it is important that the coating is flexible enough to withstand the expansion. PEGDA
films have good coating properties and for possible future application of PEGDA films as
drug eluting coatings we want to investigate their behavior as drug carriers and their
ability to control the drug mobility and the drug release.
PEGDA polymers are based on poly(ethylene glycol) (PEG) which makes them
friendly to the human body. PEG-containing materials have been the subject of
significant research for applications as controlled release devices. The PEG polymer
possesses desirable properties as a drug carrier such as good water solubility, low toxicity
and biocompatibility. Cross-linking of these polymers enables tuning of solute release
behavior and controlled delivery of proteins10,11, as well as small molecular weight
drugs12. The use of photopolymerized PEG-based hydrogels for medical applications was
first proposed by Hubbell et al.13,14 The UV polymerized gels were applied for sustained
and controlled release of Albumin. Later, Cruise et al.15 studied the diffusion behavior of
different biological molecules in cross-linked PEG diacrylate hydrogels. Scott and
Peppas16 developed ionizable networks from oligo(ethylene glycol) (OEG) multiacrylates
and acrylic acid. They studied the swelling behavior as a function of copolymer
composition and pH and demonstrated precisely tuned release behavior of the low
molecular weight drug proxyphylline. Mellot et al.17 investigated the release of a high
molecular weight protein from PEGDA. Litvinov and Dias18 investigated the structure
and properties of PEGDA networks by 1H NMR relaxation, 13C NMR spectroscopy and
dynamic mechanical experiments.
For most investigations published so far the emphasis is mainly on the direct relation
between properties of the release matrix (cross-link density of the matrix, copolymer
composition) and the release curve of a drug from these matrices. The drug release curve
is the concentration-time curve which describes the drug release profile and from which
the release rate can be determined. One can argue that the release curve indeed is the
most valuable information for a drug release system. Nevertheless, a drug release curve
results from a complex interplay of drug-matrix interactions, matrix swelling, drug
solubility, drug and swelling solvent mobility. In this thesis we approach the problem by
concentrating on the molecular drug-matrix interaction and the drug diffusional mobility
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(lateral and rotational) in the matrix. The central question is the effect the matrix has on
the mobility of the drug in relation to the matrix network mesh size and the drug size.
Cyclodextrins  are  important  in  drug  delivery  due  to  their  ability  to  modify  the
drug release from hydrophilic matrices19. We also want to investigate whether it is
possible to increase the retention time of a certain drug molecule in the polymer matrix
by complexing the drug to a host molecule such as cyclodextrin.
We also show that for one particular insoluble drug molecule complexation with
cyclodextrin leads to the formation of a novel drug delivery system without the need for a
polymer matrix. This system is composed only of drug and cyclodextrin and here we
report about its properties and its potential applications.
Theoretical aspects
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2.1 Hydrogels
2.1.1 Composition and structure of hydrogels
Hydrogels studied here consist of polymer networks. Polymers are molecules
composed of a large number of covalently bound repeating units which can be spatially
arranged in different ways. If the repeating units are identical the material is termed a
homopolymer. If different structural units are presented in a chain the polymer is called a
copolymer.  In  terms  of  spatial  arrangement  polymers  can  be  organized  such  that  they
form a linear sequence of structural units, linear polymers, such as in Fig. 2.1:
A B A B A A B
Fig. 2.1: Linear polymer
More often polymer systems are encountered where the structural units are connected to
form nonlinear or branched structures (Fig. 2.2).
A B A A A B A
A
A
A
A
Fig. 2.2: Branched polymer
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Three-dimensional (3D) network structures can be formed starting from linear
polymer chains by introduction of intermolecular cross-links. The formation of cross-
links joins units which belong to different molecules. A cross-linked system is presented
in  Fig.  2.3.  There  are  different  definitions  of  a  polymer  network,  but  it  has  to  be
mentioned  that  a  cross-linked  polymer  and  a  polymer  network  does  not  necessarily
represent  the  same  thing.  Not  every  cross-linked  polymer  represents  a  network.  If  the
cross-linking is below a certain degree (gel point), the polymer is considered as branched.
The gel point represents the state where enough polymer chains are linked. Above this
limit one can talk about network structure. In chemical networks cross-links are covalent.
In physical networks cross-links are formed by physical interactions. Junction points can
then be caused by entanglements, crystallites or due to weak interactions (hydrogen
bonding, van der Waals forces).
B A A A B A B
A A A B A A AB
X
B B A A A
X
Fig 2.3: Cross-linked polymer
The properties of a cross-linked network depend on the average molecular weight
between cross-links. For a better understanding of the degree of cross-linking and later
the swelling behavior of polymer networks, it is important to introduce the terms
“polymer molecular weight” and “degree of polymerization”. Polymers with identical
chemical composition exhibit different properties depending on the length of their chains.
Similarly, networks with different average chain lengths between cross-links will have a
different  behavior.  For  characterization  of  the  polymer  chain  length  a  degree  of
polymerization (DP) has been introduced. The polymerization degree, DP, represents the
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number of repeat units in the polymer chain. It also gives a measure of polymer
molecular weight.
0M
MDP ?                                                       (2.1)
In  this  equation  M  represents  the  total  molecular  weight  of  the  polymer  and  M0 the
molecular weight of the repeating unit.
A distinction has to be made between the number average and the weight average
molecular weight of a polymer. The number average molecular weight, nM , is the  total
weight of all polymer molecules divided by the total number of the polymers:
?
?? ????
i
ii
iin N
MN
MnM                                              (2.2)
Mi represents the molecular weight of polymer chain i, Ni is  the  number  of  moles  of
chains i and ni the mole fraction of chains with molecular weight Mi.
The weight average molecular weight, wM ,  is  based  on  the  fact  that  a  larger  polymer
species contains a larger fraction of the total mass of the polymer sample than the small
polymer species.
? ?? iiw MwM                                                        (2.3)
wi , the weight fraction of chains with molecular weight Mi, can be obtained by dividing
the mass of species i with molecular weight Mi by the total mass of all polymer species
present:
? ?
??
ii
ii
i MN
MNw                                                         (2.4)
The weight average molecular weight then becomes:
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?
?
?
??
ii
ii
w
MN
MN
M
2
                                                      (2.5)
The wM  is proportional to the square of molecular weight and is always larger than the
number averaged molecular weight (Fig. 2.4).
Molecular weight
Nu
m
be
r o
f p
ol
ym
er
s
Number
average, M
n
Weight
average, M
w
Fig. 2.4: Distribution of molecular weights in a polymer
The ratio of the weight average and the number average molecular weight describes the
distribution of chain lengths, i.e. polydispersity of the sample. For most polymers this
ratio is between 1.5 and 2.5. For monodisperse polymers Mw/Mn is close to 1.
For characterization of a network structure, the degree of cross-linking is a very
important property. The degree of cross-linking (X) represents a measure of the extent to
which a polymer is cross-linked. It can be determined as the number density of junctions
(cross-links) which join the chains into a permanent structure:
V
X
2
??                                                            (2.6)
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?  is the number of cross-linked units, 2/?  is the total number of cross-links and V the
total polymer volume. A higher degree of cross-linking causes a restriction of chain
mobility in the polymer.
2.1.2 Properties and swelling behavior of hydrogels
Hydrogels are water insoluble cross-linked network structures which are able to
swell in the presence of water and thus can absorb a large amount of water. The network
in a gel can be classified by the type of cross-links into physical and chemical networks.
Prediction and control of mechanical properties of hydrogels is very important for
many applications. It is known that hydrogels which exhibit high swelling possess poor
mechanical strength, while lowering of the swelling degree improves their mechanical
properties20. Most of the swollen hydrogels fulfill the criteria for rubber materials. That
implies that after applying mechanical stress or strain they have the ability to rapidly
rearrange their polymer chains and to completely recover after removal of the stress. By
decreasing the temperature this property can be lost and the gels exhibit viscoelastic
behavior. Viscoelastic properties assume that after removal of deformation hydrogels
need a long time for the complete recovery.  If the recovery can not be completed, the
materials are viscoplastic. Rubberlike properties of gels are the high extensibility, which
can be achieved by low mechanical stress, and rapid recovery21. During swelling the
thermodynamically driven swelling force is counterbalanced by the retractive force of the
polymer structure and the equilibrium is achieved when these two forces become equal.
Tuning of rubber elastic behavior can be achieved by varying the ratio and type of
comonomers in the gel, by changing the cross-link density and by controlling the
polymerization conditions. Increasing the amount of hydrophobic components improves
the mechanical properties of hydrogels. A higher cross-linking degree leads to an
increase of mechanical strength. During polymerization different parameters can be
varied (temperature, solvent, reaction time) which will affect the elastic behavior of
hydrogels. Mechanical properties determine the swelling behavior and the possible
application of hydrogels.
Theoretical aspects
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Ideal network structures are very rarely encountered22.  In  such  a  structure  each
junction is covalent and tetrafunctional. More often gels contain irregularities in the
structure in form of multifunctional cross-links or entanglements which could be
permanent or semipermanent (virtual cross-links). Defects which appear in the cross-
linked network are dangling chain ends (unreacted functionalities) and chain loops. These
structural defects (Fig. 2.5) do not participate in the retractive force of the network.
a) b) c)
d) e)
Fig. 2.5: Network structural defects: a) ideal network; b) multifunctional junctions;
c) entanglements; d) free chain ends; e) chain loops
Due to the presence of cross-links gels cannot dissolve in water, but when they are placed
in a water solution they expand by taking up the solvent. Diffusion of water into the gel
causes stretching of polymer chains between junctions (Fig. 2.6).
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swelling
Mc, ?
Fig. 2.6: Swelling of the gel in the presence of water.
Three important parameters for structural characterization of swollen gels are the
swelling factor (Q), average molecular weight between cross-links (Mc) and network
mesh-size (?). The swelling factor represents the ratio of the volume of swollen gel (Vs)
and the polymer volume (Vp). It also equals the reciprocal of the polymer volume fraction
in the swollen gel (?2s):
sp
s
V
VQ
2
1
???                                                          (2.7)
Highly cross-linked networks exhibit lower swelling than loosely cross-linked networks
and thus have smaller swelling factors.
Mc represents the molecular weight of polymer chains between neighboring junctions.
The network mesh or pore size ? determines the average distance between cross-links
points in the gel and thereby, the degree of gel porosity.  With respect to their mesh-size
hydrogels can be divided into macroporous, microporous or nonporous gels. The higher
the  cross-link  density,  the  smaller  Mc and mesh-size are (Fig. 2.8). The swelling factor
can be determined experimentally by swelling measurements and allows the calculation
of Mc and mesh-size.
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According to the Flory-Rehner theory23 absorption of the solvent by the network
leads to stretching of chains between junctions. The chains will take less probable
configurations, which leads to decrease of entropy. At the same time an increase of
entropy occurs due to mixing of solvent with polymer. The Gibbs energy change of a
system (?G) can be defined as the sum of two contributions24: Gibbs energy of mixing
??Gmix) and the elastic Gibbs energy (?Gel):
elmix GGG ?????                                                     (2.8)
The corresponding change of chemical potential is then:
elmix ??? ?????                                                      (2.9)
The Gibbs energy of mixing is:
mixmixmix STHG ??????  ,                                                (2.10)
where ?Hmix is the mixing enthalpy, ?Smix is  the  entropy  of  mixing  and  T  is  the
temperature. The enthalpy of mixing is24:
21 ?? ?????? nTkH bmix  ,                                                (2.11)
where kb is the Boltzmann constant, n1 is the number of water molecules in the swollen
gel, ?  is the polymer-solvent interaction parameter and 2?  is the polymer volume
fraction in the swollen gel. The entropy of mixing is given24:
? ?2211 lnln ?? ??????? nnkS bmix   ,                                       (2.12)
where again n1 is the number of water molecules in the swollen gel and 1?  is the volume
fraction of water ? ?121 ???? . Assuming that in the gel the number of free polymer
molecules (n2) is zero, the Gibbs energy of mixing becomes:
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? ? ? ?? ?21212111 1lnln ?????? ???????????????? nnTknnTkG bbmix            (2.13)
The difference between the chemical potential of the solvent in the gel (?) and in the free
solution (?0)  can  be  obtained  by  differentiation  of  ?Gmix with  respect  to  the  number  of
solvent molecules:
? ?? ?22220 1ln ??????? ?????????? Tkbmix                             (2.14)
Multiplication with Avogadro’s constant gives the chemical potential difference per
mole:
? ?? ?22221ln ????? ???????? TRmix                                     (2.15)
The Gibbs elastic retracting energy per mole was determined by Flory24:
? ?32 ln33
2
??? ??????? eel
TRG                                         (2.16)
where e?  is  the number of effective chains (excluding free ends) and ? is the linear
expansion factor of the network. The change of chemical potential due to the elastic
retractive force is:
?
?
??
?
? ?????????
?
???
?
?
???
2
23/1
2
0
1
,1
????
V
VTR
n
G e
PT
el
el                                 (2.17)
V0 represents  the  volume  of  the  unswollen  polymer  and  V1 the molar volume of the
solvent. The total change of the chemical potential is the sum of two contributions and
when the state of equilibrium swelling is reached, it equals zero:
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0?????? elmix ???                                                 (2.18)
From this condition Flory derived an equation for calculation of the Mc value from the
swelling ratio obtained in the equilibrium swelling experiment:
? ?? ?
2
1ln
21
23/1
2
2
222
1
??
?????
?
?????
?? V
MM nc
                                    (2.19)
?  is the specific volume of the polymer. This equation was later used, either in original
form or in modified form by Bray and Merill25, for evaluation of the average molecular
weight between cross-links.
Once  Mc is known, the network mesh-size (?) can be estimated according to the
procedure derived by Canal and Peppas26. At first the average end-to-end distance of the
polymer chains between cross-links in the absence of swelling water ?
?
??
?
? 2
0r  has to be
calculated. It depends on the number average molecular mass of the chains between
cross-links:
r
c
n M
M
Clr ???? 220                                                (2.20)
where l is the bond length of the polymer repeating unit, Cn is a ratio characteristic for the
polymer and Mr is the molecular mass of the polymer repeating unit. The mesh-size of
the network is related to the swelling factor of the polymer :
3
2
0
3/1
2
2
0 Qrr ???? ???                                             (2.21)
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If a gel is swollen in water above the equilibrium condition (more water than the
maximum amount the gel can take up), two phases will appear: a hydrogel phase and a
water phase. The T-w2 phase diagram of a hydrogel, where w2 is  the weight fraction of
the  polymer,  represents  various  phases  of  the  binary  gel-water  system  and  conditions
under which these phases coexist. Hydrogel properties can be thus interpreted on the
basis  of  a  T-w2 phase diagram. The line on the diagram which shows the maximum
amount of the water that can be added to the polymer before a second phase (free water)
appears is the swelling curve of the hydrogel. The schematic representation of a hydrogel
phase  diagram  is  shown  in  Fig.  2.7.  As  the  water  can  exist  in  three  different  states  of
matter, liquid, vapor and crystal, there can be three different equilibria between a gel and
a solvent27.  Borchard  et  al.27 investigated swelling of a cross-linked substance in
equilibrium with a solvent. They found that in the cases where the temperature is between
melting and boiling point of the solvent, the swelling curve will be almost parallel to the
ordinate in the temperature-weight fraction diagram.
T
w2water
cross-linked
polymer
2 phases 1 phase
x y
Fig. 2.7: Schematic representation of a binary phase diagram of hydrogel. The blue circle
represents an overall composition in the two-phase area and the red line the swelling
curve of a hydrogel.
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An  isothermal  line  intersecting  the  swelling  curve  is  called  a  tie  line.  The  ratio  of  two
phases in a two-phase diagram at a given temperature can be obtained by the lever rule.
From Fig. 2.7, the weight fraction of the gel in the binary mixture is:
? ?
xy
xgelf
?
?                                                    (2.22)
According to this rule, the relative amount of a gel phase in the two-phase gel-water
system is proportional to the fraction of tie line between the overall composition and the
temperature axis of the diagram.
2.1.3 Polymeric hydrogels and drug release
In polymeric drug delivery systems different mechanisms can be applied to
control the release of drugs28. Three different types of controlled devices are often
encountered: diffusion-controlled systems, swelling-controlled systems and erosion-
controlled systems. In diffusion-controlled and swelling-controlled devices the hydrogel
matrices swell due to water penetration and the drug molecules can be released from the
matrix via diffusion.
In diffusion-controlled systems the drug diffusion rate determines the drug release rate
from the polymer. In a polymeric matrix the polymer represents an obstruction for drug
diffusion and decreases the drug release rate. Swelling of the polymer lowers this
diffusion barrier because big pores are formed through which drugs can easily diffuse
out. Two kinds of diffusion-controlled systems are known: reservoir based devices and
matrix based devices (Fig. 2.8). The reservoir devices possess a core filled with the drug,
which is surrounded by a polymer membrane in order to slow down the drug release.
Matrix or monolithic devices contain a drug which is dispersed throughout the polymer
structure and release occurs by diffusion through the polymer.
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t = 0
t = T
t = 0
t = T
drug
polymer
drug dispersed
in polymer
a) b)
Fig. 2.8: Diffusion-controlled drug delivery systems: a) reservoir devices b) matrix
formulations
In swelling controlled systems the drug is initially dispersed in a glassy polymer and is
unable to diffuse (Fig. 2.9). During swelling the polymer undergoes a transition from the
glassy to rubbery state. Only the drug in the swollen part of the polymer can diffuse out.
In that process several fronts are formed, where a front represents a boundary between
gel regions where the gel properties sharply change (Fig. 2.9). Colombo et al. described
the movement of gel fronts and their influence on the drug release rate29. The swelling
front divides the glassy polymer from the swollen region. The erosion front separates the
matrix from the surrounding solvent. Between these two fronts a diffusion front can be
observed which represents a boundary between a solid drug and a dissolved drug. Its
position depends on the drug dissolution rate in the gel. If the swelling and erosion front
move synchronously, the gel layer thickness will remain constant and zero-order release
can be achieved. This means that drug will be released from a polymer at a constant rate.
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t = 0
t = T
drug dissolved in
glassy polymer
glassy polymerswollen polymer
swelling front
diffusion front
erosion front
H2O
H2O H2O
Fig. 2.9: Swelling-controlled drug delivery system
In the erosion-controlled systems a drug is dispersed in a polymer matrix and can only
be released by erosion of the device itself (Fig. 2.10). The release rate is determined by
the erosion rate and if it is constant, zero-order release can be obtained.
t = 0
t = T
drug dispersed
in polymer
polymer
Fig. 2.10: Erosion-controlled drug delivery system
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Ritger and Peppas developed an equation for description of the release kinetics from
swellable polymeric devices30:
nt tk
M
M ??
?
                                                         (2.23)
where Mt is the amount of drug released at time t, M? is the amount of drug released at
infinite time, k is the kinetic constant and n is the diffusion exponent. When n equals one,
the drug release will be zero-order. The drug release curve can be obtained by measuring
the amount of released drug in certain time intervals (Mt = f (t)) and it represents an
overall manifestation of the release properties of a matrix.
2.2 Diffusion
2.2.1 Principles of molecular diffusion
Molecular  diffusion  can  be  described  as  a  random  translational  motion  of
molecules driven by their thermal energy. Thermal motion is random, which means that
the molecules will tend to move down a local concentration gradient. A distinction can be
made between two types of diffusional motion: transport diffusion and self-diffusion.
Transport diffusion represents the net movement of molecules resulting from an overall
concentration gradient. Self-diffusion relates to the motion when the chemical potential
gradient equals zero and the quantity describing the migration rate in the macroscopic
equilibrium is known as the self-diffusivity. Because it is more convenient to study
systems under equilibrium conditions, most diffusion studies are related to the self-
diffusion measurements.
Adolf Fick introduced two differential equations describing the Brownian motion under a
concentration  gradient.  The  first  law  relates  the  flux,  J(r,  t)  (which  is  a  vector),  to  the
concentration gradient31:
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? ? ? ?trcDtrJ ,, ????  ,                                                 (2.23)
where D is the (transport) diffusion coefficient in units length2/time  and  c(r,  t)  is  the
concentration. The negative sign indicates that the migration occurs in the direction of
lower  concentration.  The  diffusion  coefficient  increases  with  the  temperature  and  is
inversely  proportional  to  the  mass  of  the  diffusive  species.  The  second  Fick  law  states
that the change of concentration in time is equal to the local change of flux:
? ? ? ?trJ
t
trc ,, ????
?                                                    (2.24)
Combining this equation with Fick’s first law, the equation is obtained which describes
the change of concentration gradient with time31:
? ? ? ?trcD
t
trc ,, 2 ?????
?                                               (2.25)
Equation 2.25 can be applied only in the case of isotropic diffusion.
The diffusion process can be interpreted as a random walk, where the movement
of each particle is represented by a sequence of steps or jumps, equal in size and with
equal probability in any direction. The jump frequency is assumed to be constant. The
property of random walk is the independence of individual steps whereby the movement
of  a  certain  particle  does  not  depend  on  its  history,  but  only  on  its  position  before  the
jump.
In order to determine the mean square displacement of such a molecule we can observe
the propagation of a large number of molecules (an ensemble). The movement of a
molecule i can be characterized by a time-dependent displacement vector ri(t). If a
molecule i had a displacement ri at  t  =  0,  the  function  which  gives  a  probability  that  a
certain molecule j will be found at a position jr?  at  time  t,  is  known  as  the  correlation
function32 ? ?trrP ji ,? .  This  function  is  sensitive  to  relative  motions  and  it  correlates  the
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displacements of ? ?0ir  and ? ?tr j?  both  for  i  =  j  and  i  ? j.  For  this  reason  the  self-
correlation function32 (i = j) has been introduced, ? ?trrPs ,? , which gives the probability
that a molecule at a position r  at t = 0 will run a distance R in a time t and move to a new
position r?  (Fig. 2.11). This function is also called the propagator and contains the
maximum  information  about  the  system.  The  total  probability  to  find  a  particle  at  the
position r?  at the time t, ? ?trP ,? , is given:
? ? ? ? ? ? drtrrPrPtrP s ????? ? ,0,, ,                                        (2.26)
where ? ?0,rP  represents the particle density ?(r).
r
r’
R
time = 0
time = t
Fig. 2.11: Time dependence of a particle displacement
Fick’s equation can be applied now for the case of self-diffusion if the concentration is
replaced by the propagator ? ?trrPs ,? :
sPDJ ?????  ,
s
s PD
t
P ??????
? 2                                                    (2.27)
D is now the self-diffusion coefficient.
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In the case of unrestricted isotropic three-dimensional diffusion ( sP ? 0 as r????), the
propagator, as the solution of eq. 2.27 shows, is a Gaussian function:
? ?
? ?
? ?
Dt
rr
s e
Dt
trrP 4
2
3
2
4
1,
???
???
?
                                         (2.28)
In a similar way, the average propagator can be determined, ? ?tRPs , , giving the
probability that a certain particle will have a net displacement R over a time t:
? ?
? ?
Dt
R
s e
Dt
tRP 4
2
3
2
4
1,
?
??
?
                                           (2.29)
In the case of one-dimensional diffusion along the z-axis, the mean square displacement
can be now calculated by integration:
? ? ? ?????? ?????? tDdztZPztz 2,22  ,                                     (2.30)
where Z = z’(t) - z(0). For three-dimensional diffusion the mean square displacement
becomes:
? ? tDtR ??? 62     ,                                         (2.31)
which is the Einstein-Smoluchowski equation.
2.2.2 Physical models for diffusion of small molecules in polymer gels
In order to be able to control the diffusion of drug molecules in polymers, a
detailed understanding of the molecular diffusion process in polymer solutions and gels is
needed. For this purpose it is necessary to determine how the molecular size and shape of
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the solute molecule as well as the specific interactions between a matrix and a solute
affect the diffusion behavior within the gel. It is known that the diffusion rates in gels are
between those in solids and liquids. In order to relate diffusivity to structural properties of
a swollen gel, various models for the description of diffusion of small molecules in
polymer gels have been developed33,34. They have been divided into models based on
obstruction effects, Free Volume Models and hydrodynamic models.
Models based on obstruction effects. These models are also known as lattice
models because the gel is considered to form a polymer-solvent lattice. Here, the
diffusion  of  small  molecules  in  the  gel  is  described  to  take  place  in  the  solvent  of  the
swollen gel. The polymer chains act as obstructions for this diffusion because the lattice
sites occupied by the polymer are not available to drug or water molecules. Increase of
the  polymer  concentration  in  the  gel  leads  to  a  decrease  of  the  solute  diffusion
coefficient. Mackie and Meares35 developed a concept for description of the diffusion of
electrolytes in a resin membrane. According to them, the diffusion of a small molecule in
a gel is a function of the volume fraction, ?2, occupied by the polymer in the gel (in the
absence of the diffusing molecule):
2
2
2
0 1
1
???
?
???
?
?
?? ?
?
D
D                                                        (2.32)
D is the self-diffusion coefficient of the diffusing molecule in the gel phase and D0 is the
self-diffusion coefficient in the water phase without the polymer matrix. With increasing
cross-link density, ?2 increases due to the fact that a higher cross-linked network takes up
less water upon swelling. The shortcoming of this approach is that it does not consider
how the size and shape of the solute affect the diffusion coefficient.
The same lattice concept was improved by Ogston et al.36, by taking into account the
solute size. They assumed that the diffusion of variously sized molecules takes place in a
solution of long molecular fibers with negligible width. The diffusion coefficient depends
both on the size of solute and the size of molecular fiber:
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where rs is the hydrodynamic radius of the molecule and rf is the cylindrical radius of the
fiber.
All these lattice models provided good results only for small-sized molecules in dilute
polymer solutions and their main drawback is that the interaction between the diffusing
molecule and the polymer matrix is described as between hard spheres.
Free Volume Models. These models assume that the molecular diffusion in the
gel occurs due to random distribution of free volume voids in a polymer matrix. The
diffusion process can be then interpreted as a sequence of jumps of a molecule into holes
created by the thermal rearrangement of all species. The diffusion coefficient will be
determined by the probability that there exists a hole larger than a critical size in which
the molecule can move. Increase in polymer concentration reduces this probability, and
therefore leads to decrease of the solute diffusion coefficient. The well-known concept
was developed by Yasuda et al.37.  Assuming  that  the  free  volume  of  the  system  arises
mainly from the solvent contribution they developed the following equation:
?
?
?
?
?
?
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?
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?
???? 20 1
11exp ?wf
B
D
D    ,                                   (2.34)
where B is the minimum size of the hole necessary for the solute movement and fw is the
solvent free volume. These models were successfully applied in the cases of low
concentrated drug solutions, but in general they also neglect the existence of interaction
between the solute and the polymer matrix.
Hydrodynamic models. These concepts treat polymers as mobile species and
also consider hydrodynamic interactions between all components in the system: the
interactions of the solute with the polymer, solute with the solvent and the interactions of
the  solvent  with  the  polymer.  Philies  developed  an  equation  based  on  experimental
results38:
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? ?vceDD ???? ?0  ,                                                (2.35)
where c is polymer concentration. ? and ? are scaling parameters which depend on the
size of solute molecule. This equation provided good results for polymer solutions of
different concentrations and for solutes ranging from small-sized molecules to
macromolecules, but the scaling parameters ? and ? miss physical meaning and
theoretical justification.
Many of the suggested diffusion models were not able to explain the temperature
dependence of diffusion coefficient. Experiments have shown that often this dependence
is exponential and can be described by the Arrhenius equation:
TR
Ea
eDD ?
??? 0   ,                                                        (2.36)
here R is the universal gas constant, T the absolute temperature and Ea is the activation
energy of diffusion. This equation is only valid in dilute polymer solutions. According to
this equation a molecule can move from its surroundings into a neighboring hole only if it
acquires sufficient energy to overcome the activation energy or the diffusion barrier. If
the activation energy is known useful information about molecular motion in the gel can
be obtained.
The diffusion of small molecules in polymers is a very complex process and that is why
different theories exist trying to integrate the effects of molecular size and shape and
specific interactions on the solute diffusion behavior. In many cases attempts to improve
the existing theories are needed in order to accurately describe the drug diffusion in
polymer gels.
2.3 Molecular rotation in liquids
The magnetic resonance method (will be discussed in Chapter 3) represents a
valuable tool for the investigation of molecular rotational motion in liquids39. Basic
Theoretical aspects
29
information  about  molecular  mobilities  can  be  provided  by  NMR  relaxation
measurements. The T1 relaxation time is a time constant for the longitudinal (spin-lattice)
relaxation process and T2 is a time constant for the transverse (spin-spin) relaxation. The
molecular correlation time for isotropic tumbling motion or rotation, ?c, determines the
frequency of molecular reorientation and represents the average time for one rotation to
take place39. In the simplifying case of isotropic rotational motion and relaxation through
dipolar interaction40 the  dependence  of  nuclear  spin  relaxation  times  on  the  correlation
time ?c can be easily described41. When the correlation time is short, T1 and T2 are long.
This is the situation of small symmetric molecules in a low-viscosity solvent, where they
undergo fast rotational motions and possess very short ?c values. As the correlation time
increases, T1 decreases passing through a minimum value (Fig. 2.12). A further increase
in ?c leads to an increase in T1, but T2 remains small.
Fig. 2.12: Dependence of relaxation times T1 and T2 on rotational correlation time41
Tumbling motion of molecules larger in size occurs less freely in solution and the
corresponding correlation times are longer. For those molecules which can fast and freely
rotate, T1=T2. In most other situations differences between T1 and T2 are found.
In order to describe anisotropic molecular rotation in liquids it is necessary to
introduce a model for the motion. Most molecules are asymmetric and their rotation is
not isotropic, but preferred axes of rotation exist. In general the rotational motion about
different axes occurs at different rates. For such a study the planar benzene molecule has
been taken as an example42. Woessner et al. found that for such an axially symmetric
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molecule which undergoes rapid anisotropic motion around the two rotational axes
relaxation  times  will  be  nearly  equal  (T1?T2),  as  for  rapid  isotropic  motion.  When  the
motion is strongly anisotropic T2 is much smaller than T1.
By measuring and comparing T1 and T2 it is immediately clear if the molecular rotation is
isotropic or anisotropic. Relaxation measurements can therefore provide information
about the effects of restricted geometries in which a molecule rotates. The motion in
restricted geometries is encountered for small molecules in polymer solutions and in that
way the influence of polymers on molecular rotation can be followed. Molecular dynamic
simulations on the benzene molecule43 show that the correlation time for reorientational
motion around the symmetry axis (perpendicular to the plane) is shorter than the
correlation  time  for  the  reorientation  around  the  in-plane  axes.  That  means  that  the
rotation about the symmetry axis (spinning motion) is faster than the rotations about the
in-plane axes (tumbling motion). By introducing benzene in a polymer matrix, it was
found that the tumbling motion around the in-plane axes is further drastically slowed
down, whereas the rotation around the symmetry axis is only slightly affected.
The molecular motion of a solute in a gel is also expected to be highly anisotropic. This is
caused by the fact that for the tumbling motion around the in-plane axes molecules need
more space and the energy barrier for such motion in the gel is higher. The sensitivity of
NMR to molecular rotational diffusion makes it a useful tool to follow how the matrix
affects the rotational mobility of drug molecules.
2.4 Molecular encapsulation
Inclusion compounds (complexes) are supramolecular structures formed by
molecular encapsulation based on noncovalent interactions. These compounds represent
complexes of host-guest type. They contain a molecular species with cavity or tunnels in
its  structure  (the  host)  in  which  a  second  molecule  (the  guest)  or  some  parts  of  it  are
located (Fig. 2.13). If in the host structure the space around the cavity is closed, the guest
molecule will be entrapped like in a cage and such a complex is called a cage compound.
The association between host and guest is not based on covalent bonding and the
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molecular interaction is of the van der Waals type. Other forces like hydrogen bonding or
hydrophobic interactions also play an important role in complex formation. One of the
most common techniques to follow the formation of inclusion compound is NMR.
Fig. 2.13: Example of an inclusion compound between host and guest44
Cyclodextrins (CDs) are among the most widely used host molecules and are able to
encapsulate drugs at a molecular level. Chemically they are cyclic oligosaccharides
composed of glucopyranose units linked through ?-1,4-linkages. ?, ? and ? CDs (with
six, seven and eight glucose residues, respectively) are hollow molecules which enclose
cavities of 5-8 Å in diameter. The outer surface of a CD molecule is hydrophilic while
the inner cavity is hydrophobic. The lipophilic environment enables cyclodextrins to
build inclusion complexes with many different drug molecules.
The most common way to prepare a CD-drug inclusion compound is by mixing an excess
of the drug with cyclodextrin in solution and after equilibrium is reached to filter the
mixture to obtain a clear drug-CD complex solution. Most frequently formed are 1:1
complexes, but also 2:1, 1:2 and other more complicated associations are encountered.
Binding of a guest molecule to a CD in the case of 1:1 complex can be represented by the
equilibrium reaction:
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+ ?
?
K
CD DRUG COMPLEX
(DRUG-CD)
Fig. 2.14: Host-guest complexation
The above equilibrium usually is established very fast and the constant K is known as the
complex  stability  constant.  The  complex  usually  possesses  dynamic  character  which
means that the associated drug molecules are constantly exchanging with the free drug
species.
Molecular encapsulation reactions are thermodynamically driven. The driving force for
the complexation is the substitution of enthalpy rich water molecules by a guest
molecule. The cavity of CD is filled with water which is energetically unfavoured due to
polar-nonpolar interactions. On the other side, unpolar drug molecules in bulk solution
are  surrounded  by  polar  water.  The  energy  of  the  system  will  be  significantly  lowered
when the water molecules from the CD cavity are replaced by apolar drugs, which
overcomes the lowering of the entropy. There are also other factors which influence
inclusion complex formation45. Very important is that the guest is of appropriate size so
that it can physically fit into the CD cavity. Very small or very large organic molecules
will not be complexed. The complexation depends on the charges of drug and CD,
temperature of the system, presence of other substances in solution and substitution of the
parent CD molecule. The addition of polymers to a drug-CD complex solution can both
enhance or reduce complexation46,47. In some cases polymers behave as competing host
molecules for drug binding.
One of the most important applications of inclusion compounds in the
pharmaceutical field is to enhance drug stability and drug solubility, both in liquids and
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polymers48. The inclusion complex can also protect drugs from attack by various species.
Such complexes are able to modulate drug release from polymer matrices which makes
them very attractive for drug delivery. Due to the desirable properties of cyclodextrins, as
nontoxicity and water solubility, efforts are made to develop CD-based hydrogels
composed of cyclodextrins alone49.
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Chapter 3: Methods
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3.1 Nuclear Magnetic Resonance (NMR) spectroscopy
NMR  spectroscopy  is  based  on  the  fact  that  most  nuclei  possess  an  angular
momentum called spin. The angular momentum vector ? ?I?  is quantized50:
? ? ?? ???? 1III  ,                                              (3.1)
where ?2/h?? , h is Planck’s constant and I represents the spin quantum number which
can have integral or half-integral values: 0, 1/2, 1, 3/2,…
A nucleus with spin quantum number I?0 possesses besides the angular momentum also
a magnetic moment ?50:
I
?? ?? ??                                                              (3.2)
The proportionality factor?  is the gyromagnetic ratio and has a specific value for each
nucleus. If the nucleus is placed in an external magnetic field B0, the component of the
angular moment along the direction of the field is quantized50:
??? mI z    ,                                                      (3.3)
where m is the magnetic quantum number and can have values m = -I, -I+1, …I-1,I. The
spin in a magnetic field can therefore take only certain orientations and this is known as
directional quantization (Fig. 3.1).
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m= +1/2
m= -1/2
B0
I
?
Fig. 3.1: Spin with the quantum number I = ½ in a magnetic field
The energy of a magnetic dipole in a magnetic field along the z-axis ( kBB
??
?? 0 ) is50:
00 BmBBE z ?
?? ??? ???????                                         (3.4)
That means that each orientation of a spin in a magnetic field will correspond to a
different energy level (Fig. 3.2).
?E
E
m= -1/2  (?)
m= +1/2  (?)
Fig. 3.2: Energy levels of a spin (I = ½ ) in the magnetic field
If m is positive the spin is oriented parallel to the field direction which is energetically
favourable and its energy will be lower (assuming that ? is positive, there are a few nuclei
that have negative gamma). The energy difference between two neighboring energy
levels is:
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0BE ????                                                         (3.5)
According to quantum mechanics only transitions between adjacent levels are allowed
??m= ±1). Because this energy difference is much smaller than the thermal energy (kBT),
the populations of both levels are almost equal. At room temperature there is a slight
excess in the lower energy level:
?
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B   ; 610???                                   (3.6)
In a system with N spins the sum of all magnetic moments forms a macroscopic
magnetization and is represented by a vector oriented along the field direction.
Irradiation of spins with electromagnetic waves whose energy corresponds to the
energy difference between two spin states leads to transitions between the levels.
Absorption of photons can occur if the resonance condition is satisfied:
01 BEh ??? ???                                                     (3.7)
This is the basis of the continuous wave (CW) NMR technique. The interaction between
spins and radiation causes induced absorption, induced emission and spontaneous
emission  transitions.  According  to  Einstein  the  two  induced  transitions  have  the  same
probability and spontaneous emission can be neglected for NMR. In the CW experiment
there are two ways to achieve resonance, one is by keeping the frequency ?1 constant and
changing the magnetic field strength B0 and the other is to vary the frequency of radiation
at a constant value of B0. The NMR spectrum is obtained when the absorbed energy ?E is
represented versus B0 (at the constant ?1) or versus ?1 (at constant B0) (Fig. 3.3).
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?E
01 Bh ??? ?1? 0B
Fig. 3.3: The NMR spectrum
3.1.1 The pulsed NMR spectroscopy
In the continuous wave method the spectrum is measured by using only one
frequency which is inefficient because most of the experiment time will be used for
detecting the base line between resonances. A much more efficient way of exciting the
spins is by using a pulsed radiation field. Fourier Transformation (FT) of such a pulse
function has shown that the pulse contains a band of frequencies symmetrical about the
central frequency ?151. The shorter the pulse, the larger the frequency range it includes.
The frequency components located farther away from ?1 possess lower intensities and in
order to obtain a broad excitation spectrum very short and strong pulses are applied
(“hard pulses”).
In the classical interpretation each spin in the magnetic field precesses around the field
axis  with  the  Larmor  frequency  ?0= ?·B0. The macroscopic magnetization under
equilibrium  conditions  is  along  the  field  direction.  In  the  NMR  experiment  a  radio-
frequency (rf) pulse is applied to the sample along the x axis. Quantummechanically this
leads to transitions between spin states, but in the classical interpretation the rf excitation
causes the magnetization to tip away from the equilibrium orientation along B0. After the
pulse the macroscopic magnetization will then also start to precess around B0 with the
frequency ?0 (Fig. 3.4)
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?E=?? 0
?
?
B0
?0
a) b)
M
?
Fig. 3.4: Interaction of the spin system with the rf radiation in the quantum-mechanical
interpretation (a) and classical interpretation (b)
In order to explain the interaction between spins and external magnetic field a
rotating coordinate system has been introduced. This system with the axes x’, y’ and z’
(z’|| z) rotates around the z axis with the frequency ?, the frequency of the excitation
field, in the direction of precession. In this system a virtual field, Bvirt,  has  to  be
introduced51. The linearly oscillating magnetic field produced by rf pulse, for instance
along the x axis, can be represented as the sum of two vectors with magnitudes (B1)
rotating in the x-y plane in opposite directions. Only the component which rotates in the
direction of precession, in first order interacts with the spin system. (Fig. 3.5).
B0
BvirtB1
Beff
x’
y’
z
Fig. 3.5: Effective magnetic field in the rotating coordinate system
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In the rotating coordinate system during the excitation rf pulse there are three magnetic
fields:  B0,  Bvirt???? and B1,  which contribute to the total  effective field Beff. In the case
when the photon frequency equals the resonance frequency ?0, Beff becomes equal B1.
If the pulse with the time length ? and the frequency ??? 0 is  applied  to  the  system in
equilibrium, the only field in the rotating coordinate system is B1. The magnetization will
start to precess around the field B1.  The effect  of B1 is to turn the magnetization vector
around the x’ axis in the y’-z plane over an angle ?. This angle is known as the flip angle.
It depends on the pulse duration, applied field B1 and the gyromagnetic ratio:
??? ??? 1B                                                           (3.8)
By  varying  the  pulse  length  it  is  possible  to  adjust  the  value  of  the  angle  ?.  Two
important cases are 900x and 1800x pulses, where the magnetization is turned through the
angle ?/2 and ?, respectively, around the x’ axis (Fig 3.6.).
x’
y’
z
M
M (?/2)
M (?)
Fig. 3.6: Magnetization vector before pulse (black), after a 900x pulse (blue) and after a
1800x pulse (red)
3.1.2 Relaxation
After applying rf radiation the spins absorb photons and undergo transitions
between energy levels. These transitions tend to equalize the populations of the two
involved levels (saturation). Further absorption of radiation would then be impossible if
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there would not be relaxation phenomena32. When the pulse is turned off, the
magnetization vector is turned over an angle ? and the system is not in equilibrium. The
relaxation processes which try to restore the equilibrium state are spin-lattice and spin-
spin relaxation. In the equilibrium state magnetization is parallel to the magnetic field.
During these processes the magnetization component Mz will increase to its original value
M0, while Mx and My will decrease to zero.
Spin-lattice relaxation involves an exchange of energy between spins and their
surrounding (lattice). Under the term lattice are assumed all degrees of freedom other
than  from  the  spins  of  a  system.  This  relaxation  pathway  enables  restoring  of  the  Mz
component of magnetization (longitudinal relaxation)32:
1
0
T
MM
dt
dM zz ???   ,                                                  (3.9)
where T1 is the spin-lattice relaxation time.
The transverse relaxation process includes exchange of energy between spins
and describes the decay of Mx and My magnetization components to zero32:
2
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T
M
dt
dM yxyx ??   ,                                                      (3.10)
where T2 is the spin-spin relaxation time. Also this decay is exponential:
? ? ? ? 20,, T
t
yxyx eMtM
?
??                                                  (3.11)
The exchange of energy between spins and lattice is always less probable than among the
spins themselves and therefore T2 cannot be longer than T1 (T2 ? T1).  The  T2 time
determines the width of the resonance line in the NMR spectrum. Usually the broader the
line, the more rigid is the part of the sample where the spin is located.
Methods
42
3.1.3 Pulse techniques
Different combinations of applied pulses can be used for determination of T1 and
T2 relaxation times, as well as for measurement of molecular self-diffusion coefficients32.
The majority of methods are based on the application of combinations of 900 and 1800
pulses.
a) Inversion recovery method
The inversion recovery method is used for determination of the spin-lattice
relaxation  time.  The  T1 time is very important because it provides information about
molecular mobilities. The pulse sequence is represented in Fig. 3.7.
1800x 900x
?t ?0t ?
M0
Fig. 3.7: Inversion recovery pulse sequence
The 1800x pulse inverts the magnetization vector M0 and  it  becomes  antiparallel  to  B0.
The longitudinal relaxation process proceeds for a time ?. The following 900x pulse
rotates the magnetization M(?) into the x-y plane and the intensity of the NMR signal is
proportional to M(?). By measuring M(?) for different time intervals the T1 time can be
calculated:
Methods
43
? ? ???
?
?
?
?
?
????
?
1210
TeMM
?
?                                             (3.12)
b) The Spin-Echo (Hahn-Echo) experiment
The Spin-Echo experiment is one of the basic and widely used NMR techniques
for obtaining different kinds of information. The pulse sequence is shown in the Fig. 3.8.
900x
?t ?0t ? ?t ?? 2
M0
1800x spin-echo
Fig.3.8: Spin-Echo pulse sequence
Due to inhomogeneity of the magnetic field or small differences in chemical shift, spins
in a sample usually precess with different resonance frequencies. The 900x pulse brings
the total magnetization vector in the x-y plane. There, the magnetizations from different
spins precess at different frequencies and that causes a dephasing of the transverse
magnetization. After a time interval ?, a 1800x pulse is applied which deflects each vector
through 1800. The magnetizations remain in the x-y plane but after the pulse the vectors
with lower precessing frequencies are in front of the vectors with higher frequencies. In
that way the initial apparent loss of spin coherence is reversed and after the time ? (at t =
??) all spins independent of their frequency become phase coherent and build a spin-echo
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signal. The echo attenuation is caused only by the spin-spin relaxation and this technique
is therefore used to determine the T2 relaxation time. With increasing time ?, the echo
amplitude decreases:
? ? *2
2
02
TeME
?
?
??
??                                                        (3.13)
The time constant *2T  usually is longer than the T2 time determined from the line width.
Both relaxation times are influenced by molecular mobility and become shorter with
increasing rigidity of a sample.
c) The Stimulated-Echo experiment
As already mentioned, in materials in which molecular motion is extremely slow,
the  T2 relaxation time is significantly shorter than the T1 time. That means that the
transverse magnetization exists only over a short period of time. For diffusion
experiments, one often needs to increase the observation time and this becomes possible
if the transverse magnetization is stored for a certain time. This can be achieved by the
stimulated-echo method whose pulse sequence is shown in the Fig. 3.9.
900x
1?t ?0t ?
M0
900x 900x
2?t ?
21 ?? ??t
stimulated-echo
Fig. 3.9: Stimulated-Echo pulse sequence
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By  the  first  900x the equilibrium magnetization is transformed to transverse
magnetization. During the ?1 time  the  T2 relaxation proceeds. The second 900x pulse
moves the magnetization vectors in the x-z plane. Here the component of the
magnetization vector perpendicular to the field rapidly disappears (with time T2). During
the time interval between ?1 and  ?2 time the former transverse magnetization is stored
along the magnetic field B0 and is affected by T1 relaxation. Only half of the initial
transverse magnetization can be stored because its x component has disappeared. At t = ?2
the third 900x pulse is applied which inverts z-magnetization to the x-y plane. At the time
?1??2 a stimulated-echo signal is obtained. Although the signal is formed by only one half
of magnetization this technique is very useful for overcoming limitations due to short T2
values.
3.1.4 Parameters of the NMR spectrum
An isolated spin in a magnetic field possesses a resonance frequency:
0
0
0 22
B??? ?
?
?
??                                                    (3.14)
Interactions with electrons and other spins will cause a change of ?0.
a) Chemical shift
Due to the presence of electrons the effective magnetic field (Beff) at the position
of the nucleus will be less than the applied field B0. The nuclei are shielded by electrons:
? ? 000 1 BBBBeff ?????? ??   ,                                      (3.15)
where ? is the shielding constant. The resonance frequency becomes then:
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? ? 00 12 B???? ??
??                                                   (3.16)
The resonance frequency depends on the shielding constant and therefore chemically
non-equivalent nuclei of a sample will have different resonance peaks in the spectrum.
The  chemical  shift  ? is  a  dimensionless  quantity  which  describes  the  change  of  the
resonance frequency with respect to a reference substance. As reference compound
usually tetramethylsilane (TMS) is used for which it is assumed that ?(TMS) = 0.
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? values are always given in parts per million (ppm). The chemical shift depends on the
electronic structure of a molecule.
b) Spin-spin coupling
Nuclear  spins  are  magnetic  dipoles  which  can  interact  with  each  other.  This
interaction among the spins, the spin-spin coupling, also affects the magnetic field at the
position of the observed nucleus.
One type of coupling mechanism is the dipolar or direct spin- spin coupling. It plays an
important role in solid state NMR spectroscopy. The dipolar coupling represents the
direct interaction between dipole moments. The strength of the interaction depends on the
distance and relative orientations of the dipoles:
? ?
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???  ,                                     (3.18)
where ri,j is the distance between spins i and j with dipole moments ?i and ?j and ? is the
angle between internuclear vector jir ,
?  and the magnetic field 0B
?
. Depending on the
orientation  of  the  other  spin,  the  resonance  peak  of  the  observed  spin  will  be  split  into
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two peaks. In liquids due to fast molecular motion this dipolar interaction is averaged to
zero ? ?0cos31 2 ?? ? . In contrast, in solids it leads to very strong line broadening.
The other mechanism of coupling is J-coupling or indirect spin-spin coupling. It occurs
only through chemical bonds and is always intramolecular. In high-resolution NMR of
solutions it is responsible for the fine structure of the spectra. In solid state NMR it can
usually be neglected because it is many orders of magnitude smaller than the dipolar
coupling.
3.1.5 NMR self-diffusion measurements
For the measurement of molecular self-diffusion coefficients the pulsed field
gradient echo (PFGE) techniques are important31. These techniques are composed of a
sequence of rf pulses combined with field gradient pulses, which temporarily cause that
the external magnetic field is no longer homogeneous. The precession frequency of the
transverse magnetization of the spins during the gradient pulses will depend on their
location. The gradient pulses therefore lead to a rapid dephasing of the transverse
magnetization. In the case of the Hahn spin-echo sequence gradient pulses of duration ?
are applied immediately after the first and second rf pulse (Fig.3.10).
?t ?? 2
900x
?t ?0t ?
1800x
spin-echo
?
G
Fig. 3.10: Pulsed field gradient spin-echo technique
If  the  molecular  species  would  not  move  in  the  time  between  gradient  pulses,  the
dephasing of the transverse magnetization after the first gradient pulse would be
completely reversed by the action of the second gradient pulse in combination with the
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second rf pulse, as in the standard Hahn-echo experiment. But if the molecules during
that time interval move, which causes an irreversible phase shift of the spins52, the
magnetization is not fully restored and this leads to an attenuation of the echo intensity.
The time between two gradient pulses is denoted by ? and represents the time over which
the diffusion is followed, the diffusion time.  In the case of stimulated echo (Fig.  3.11)
the gradient pulses are applied after the first and third 900x pulse. This enables an increase
in the observation time for studying slower diffusion phenomena.
The spectrometer was equipped with a diffusion probe head which can impose magnetic
field gradients up to 1200 G/cm. The temperature is changed using the variable
temperature control unit. As temperature calibration an ethylene glycol sample was used,
which possesses two proton NMR signals whose chemical shift difference is temperature
dependent.
900x
1?t ?0t ?
900x 900x
2?t ?
21 ?? ??t
stimulated-echo
?
G
?
G
Fig. 3.11: Pulsed field gradient stimulated-echo technique
The Stejskal-Tanner equation53 describes the attenuation of the echo intensity as a
function of several parameters:
? ?
? ?
? ?3/222
0
??? ???????? DGe
I
gI                                                  (3.19)
where  I(g)  and  I(0)  are  the  NMR spin  echo  intensities  with  and  without  magnetic  field
gradient and G is the magnetic field gradient strength. By increasing the gradient strength
in steps and measuring the echo intensity it becomes possible to determine the diffusion
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coefficient D of a molecule. The self-diffusion coefficient can be obtained either by
exponential fitting of the data using eq. 3.19 or by calculating the negative slope of the
logarithmic Stejskal-Tanner plot (Fig. 3.12).
I(g
)/I
(0
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G2????(?-?/3)
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ln
[I(
g)
/I(
0)
]
G2????(?-?/3)
b)
Fig. 3.12: Exponential (a) and logarithmic (b) Stejskal-Tanner plot for one diffusive
species
The  diffusion  coefficient  D  for  instance  represents  a  valuable  parameter  to  distinguish
between a free molecule (A) and a molecule bound to a vehicle (B)54. The total echo
intensity will then contain two contributions:
? ? ? ? ? ? ? ?3/)3/ 222222 00 ?????? ?????????????? ?????? BA DGBDGABA eIeIIII                (3.20)
If  the  two  diffusion  coefficients  are  significantly  different,  then  it  becomes  possible  to
determine both diffusivities by applying a biexponential fit or a double linear fit (Fig.
3.13). The slope of the terminal part of the plot corresponds to the molecular species with
the slowest diffusion. From the slope of the initial part of the plot the diffusivity of the
faster molecular species can be obtained. The Stejskal-Tanner fitting procedure is done
by using Microcal Origin software.
This shows that the use of magnetic gradient techniques provides information about
molecular mobilities and opens the application for studying molecular association and
interaction with different types of molecular carriers55,56,57.
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Fig. 3.13: Stejskal-Tanner plot for two diffusive species
3.1.6 Nuclear Overhauser Effect (NOE)
a) General
The NOE effect is related to the transfer of spin polarization from one spin to
another via cross-relaxation50. The energy levels of a two-spin system with unlike spins A
and B (same spins but different chemical shifts) are shown in Fig. 3.14. In good
approximation only the transitions where one spin flips are NMR detectable. There are
therefore two resonances, an A and a B resonance (in the absence of J-coupling).
Relaxation transitions (spin-lattice relaxation) are possible between all spin energy levels
when spin-lattice relaxation is caused by modulation of the A-B dipolar coupling through
motion.
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? ?
? ?
? ?
W1A
W1A
W1B
W1B
W2
W0
A B
Fig. 3.14: Energy level diagram for a two-spin system (AB). With W are denoted spin-
lattice relaxation probabilities for transitions between spin states
In Fig. 3.14 W1A and  W1B then represent the relaxation probabilities for the single
quantum transitions. There is also a relaxation transition, the double quantum transition,
which includes a simultaneous flip of both spins (????? ??) with probability W2. The
transition with the probability W0 (??? ???) is known as the zero quantum transition. If
the A resonance is now saturated by rf excitation the populations of the levels ?? and ??
and of ?? and ?? become equal. In first instance, this has no effect on the intensity of the
B signal. If now relaxation process W2 occurs, it will lead to an increase of the population
in  the  ?? state,  thereby  enhancing  the  intensity  of  the  B  resonance.  W0 relaxation in a
similar way will lead to a decrease of the B intensity by saturation of the A resonance.
These two competing mechanisms determine the observed amplification of the B
resonance upon saturation of the A transitions. The NOE enhancement, fB(A), is defined
by the relative change of B intensity by saturation of A:
? ?
0
0
B
BBAf B
??                                                     (3.21)
B0 is the equilibrium intensity of B.
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The importance  of  the  NOE technique  is  due  to  the  fact  that  the  occurrence  of  a  NOE
enhancement implies that the two nuclear spins must be physically near (distance smaller
than ca. 0.5nm), otherwise the dipolar coupling responsible for the W0 and W2 relaxation
processes is ineffective.
b) Saturation Transfer Difference (STD) spectroscopy
The STD NMR technique is an one-dimensional NOE method for detection of
weak interactions between low molecular weight compounds and large biomolecules58,59.
The method is based on the transfer of magnetization from a spin A on a receptor to a
spin B on a ligand molecule. The spin on the receptor is selectively saturated and the
observation of an effect on one of the spins of a bound molecule enables to identify the
ligand and to screen for direct ligand-receptor interaction (Fig. 3.15).
kon
koff
receptor-
ligand complex
selective saturation pulse
free ligand
Fig. 3.15: Saturation transfer on a ligand in fast exchange between the free and the bound
state
In practice the STD experiment goes as follows. The NMR spectrum of a macromolecule
and ligand is measured, once with the saturation rf field off-resonance (reference
spectrum) and the second time under on-resonance conditions. In the off-resonance
experiment  the  sample  is  irradiated  far  away  from  the  receptor,  ligand  or  water
resonances. In the on-resonance experiment the broad signal from a macromolecule is
saturated in such a way that the ligand resonances remain unaffected. The difference
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spectrum (?I) is obtained as a difference between off-resonance (Ioff) and on-resonance
(Ion) spectra.
onoff III ???                                                         (3.16)
If the ligand or drug interacts with the macromolecule, due to saturation transfer, its
signal intensity in the on-resonance spectrum becomes lower. The longer the residence
time of the ligand or drug on a receptor, the higher its intensity in the difference NMR
spectrum. For these reasons, the STD NMR has been used as a tool for characterization
of low affinity binding between drugs and biomacromolecules. In principle the STD
NMR method is based on the NOE mechanism but is easier to execute when the NMR
resonance of the macromolecule is very broad.
3.1.7 Two-dimensional (2D) NMR spectroscopy
A general two-dimensional NMR experiment can be represented by the following
scheme60:
preparation evolution mixing detection
1t m? 2t
Fig.3.16: general pulse sequence of a 2D NMR experiment
The Free Induction Decay (FID) from such a 2D experiment depends on both the times t1
and  t2 (?m is  assumed  to  be  constant).  In  a  2D  experiment,  a  series  of  experiments  are
performed with increasing values of t1. Each FID is then Fourier transformed (FT) first
with respect to t2 then with respect to t1. Starting from a series of FIDs as a function of
two time variables S(t1, t2), the first FT converts it into a series of functions of one time
and one frequency variable S(t1,  ?2) (called interferogram). The second FT creates a
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spectrum of two frequency variables S(?1,  ?2). The 2D NMR spectrum can be
represented in three dimensions where the intensity represents third parameter.
a) Nuclear Overhauser Enhancement Spectroscopy (NOESY)
The pulse sequence of the NOESY experiment is composed of three 900 pulses
(Fig. 3.17).
900x 900x 900x
Dt 1t m?
2t
Fig. 3.17: NOESY pulse sequence
After the first  pulse spins A and B precess in the x-y plane.  The second pulse after the
time t1 puts the frequency labeled magnetizations in the x-z plane along the z-axis. The
third 900 pulse is used to measure z magnetization that remained at the end of the mixing
time. If no W0 relaxation or chemical exchange occurs during this time in the 2D NOESY
spectrum only diagonal peaks appear. Interesting information is obtained if during the
mixing time spins exchange their magnetizations, either by W0 relaxation through dipole-
dipole interactions (cross-relaxation) or by chemical exchange. Fourier transformation
with respect to t1 then gives additional cross-peaks which connect A and B (Fig 3.18).
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?A
?B
F2
F1
Fig. 3.18: Schematic plot of the 2D NOESY spectrum
The intensity of the cross-peaks depends on the NOE enhancement and the mixing time
?m. This technique has important practical applications for the structure determination of
large biomolecules, because the occurrence of a cross-peak implies that the two spins
involved in the cross-relaxation process are physically near (0.5nm).
3.1.8 Solid-state NMR
The solid-state NMR technique differs significantly from high resolution NMR of
liquids. The main reason is the much broader lines in the spectrum of a solid substance.
This broadening appears due to interaction of a spin with other nuclear spins (dipole-
dipole coupling) or with induced magnetic fields from electron motions in orbitals
(chemical shift anisotropy). These interactions are averaged for molecules in solution by
fast, random molecular tumbling motion. The line broadening in the solid-state spectra
causes also much lower signal-to-noise ratio. The additional difficulty for heteronuclei as
13C, 15N and 31P is that the T1 relaxation times in solids usually are longer than in solution
and the experiments can not be repeated so fast. The latter problem can be partly solved
by cross-polarization61.
The chemical shift anisotropy (CAS)62,63 arises because the electron clouds of a
molecule are not spherically symmetric and the chemical shift depends on the relative
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orientation of the external magnetic field with respect to the molecule. In a solution the
orientation of the molecule changes very fast and only the isotropic part of the chemical
shift remains. Magic Angle Spinning (MAS) of the sample is the well-known method to
remove the anisotropy of the chemical shift and to obtain a spectrum governed by an
apparent isotropic shift. For that purpose, the sample has to be rapidly rotated about an
axis which makes an angle of 54.70 (magic angle) with respect to the magnetic field. If
the rotational frequency is smaller than the line width, the spectrum will contain one line
at the isotropic chemical shift (centerband) and sidebands separated by the rotational
frequency. When the anisotropy is cancelled by fast rotation, the sidebands disappear.
The second source responsible for the line broadening is the dipolar
coupling62,63. As eq. 3.18 shows, the dipolar coupling depends on the orientation of the
spin pair with respect to the magnetic field. In a sample one spin feels a local magnetic
field due to coupling with its neighbors. The strength of this field varies for each spin and
is dependent on r and ? values. This causes a broad distribution of resonance frequencies.
It is assumed that the spins A are abundant and the spins B to be observed are rare spins.
That means that the homonuclear dipolar interaction between B spins is relatively small
(large average distance rij). The dipolar coupling between B and A can be removed by
decoupling, i.e. irradiation with a strong resonant rf field on the A spins. This field flips
the magnetization from A nuclei from the +z axis to the –z axis and the B nuclei feel in
average a zero local dipolar field62.
The cross-polarization between A and B spins can be performed by applying first a 900
pulse along the x axis to the A spins, which turns the A spin magnetization to the y axis.
Then a so-called spin-lock field along the rotating frame y axis is applied to the A spins,
usually with the amplitude B1A. This results in lowering of the A spin temperature. If
during this lock-field a rf field, B1B,  is  applied  to  the  B  spins  which  satisfies  the
Hartmann-Hahn condition:
BBAA BB 11 ??? ??     ,                                             (3.17)
the energy difference between spin states of spin A and spin B in the rotating frame
becomes the same (Fig. 3.19).
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AA B1?? BB B1??
Fig. 3.19: Hartmann-Hahn condition for the spins A and B
Due to dipolar interactions between A and B spins, energy exchange can occur between
the A and B spin reservoirs via flip-flop transitions. That means that a B spin flips from
its ? to ? state and provides the energy for A spins to undergo a ??? transition. When
after some time equilibrium is reached between the hot B spins and the cold A spins, the
B spins have been cooled down and one can show that the intensity of the B signal is
enhanced by a factor ?A??B. When the B spins are 13C spins and A spins protons, the gain
in intensity in the 13C NMR spectrum is about a factor 4. The CP pulse sequence is shown
in the Fig.3.20:
900x
B1A DECOUPLING
t
A
B
Fig. 3.20: CP pulse sequence
Cross polarization occurs due to dipolar interactions which decrease with the distance and
by this method only those B nuclei which are located close to A spins can be detected.
Another advantage of the CP method is that the repetition rate of the pulse sequence is
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now determined by the spin-lattice time of the A spins, although the B spin spectrum is
measured.
CP  is  often  combined  with  the  MAS  method  and  this  is  known  as  a  CPMAS  NMR
experiment.  CPMAS is the most used solid state NMR technique and enables to obtain
new information about the structure and dynamics of a solid substance.
3.2 Atomic Force Microscopy (AFM)
Atomic Force Microscopy is a mechanical imaging technique for characterization
of the topography of a surface and of its physical properties. An atomic force microscope
is able to monitor nanometer-sized features on a surface and to create three-dimensional
surface images. The main part of the microscope is the cantilever which represents a
string fixed at one end (Fig. 3.21). The free end of the cantilever contains a sharp
pyramidal tip (nanoscopic needle). The tip is brought in the proximity of the sample and
moved across its surface. By monitoring the motion of a tip across the surface, a 3D
image of the specimen is obtained.
repulsion
deflection
Fig. 3.21: AFM cantilever with the tip in the proximity of a surface
The working principle of AFM is based on the fact that the interaction between the tip
and the surface depends on the intermolecular (interatomic) distance. When two atoms
approach, they at first attract each other by a weak attractive force. When the distance
between them becomes smaller than approximately the bond distance in a molecule, a
strong repulsive force appears. The main idea is that the attraction or repulsion between
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the tip and a sample surface causes a deflection of the cantilever, to the surface or away
from it. The block diagram of an atomic force microscope is shown in the Fig. 3.22.
sample
Z PIEZO
X-Y PIEZO
photo
detector
compare
FEEDBACK
CONTROLLER
IMAGE
Fig. 3.22: Components of atomic force microscope
The principal components of the microscope are z motion generators, force sensors and
feedback controllers64.
As z motion generators piezoelectric materials are used. They possess a property to
transform electrical energy into mechanical motion. When a potential is applied to a
piezoelectric material, it will change its geometry depending on the shape and the field
strength.
Force sensors are responsible for measuring the force between the tip and the surface.
The deflection of the cantilever is proportional to the force according to Hook’s law:
dkF ???                                                        (3.18)
k is the string constant that depends on material and the shape of the cantilever and d is
the deflection of cantilever. The motion of the cantilever is measured by the “light lever”
method. A laser beam is focused on the cantilever opposite from the tip. Reflected light is
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collected by two photo detectors or by a slit detector (Fig. 3.20). Bending of the
cantilever causes a change of the position of the reflected spot and the measured
differential voltage between the two detectors represents the AFM signal.
Feedback control is achieved via piezoelectric material which controls the cantilever
position. Its function is to keep a constant force between the tip and the sample surface. A
change of the force induces a voltage in the detector which further acts on the
piezoelectric tube. That enables the establishment of the appropriate tip and surface
relative  positions.  The  x  and  y  piezoelectric  tubes  allow  scanning  of  the  whole  sample
surface.
3.2.1 Imaging modes
In the AFM technique there are several imaging modes for characterization of
surfaces65. The basic principle of moving the tip across the sample surface is common for
all of them.  The way of applying force between sample and tip can be different and one
can distinguish between the contact mode, intermittent-contact mode and non-contact
mode.
In the contact mode65 a constant force is applied to the surface and deflection of
the cantilever is a measure of this force. Changes of the sample height cause the
cantilever to bend and the feedback system re-adjusts its position to keep the cantilever
deflection  and  thus  the  force,  constant  (Fig.  3.23).  Biomaterials  such  as  polymers  often
have soft surfaces and dragging the tip across the sample can damage their surface.
Fig. 3.23: AFM contact mode
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The intermittent contact mode65 (Fig. 3.24) is widely applied for analysis of soft
materials. This is a dynamic mode where the cantilever vibrates and the amplitude of this
vibration is kept constant
.
Fig. 3.24: AFM intermittent contact mode
During these oscillations the tip comes very close to the surface where strong repulsion
occurs. If there are some features on the surface, this causes a loss of energy during
contact and the amplitude is reduced. Then the feedback system re-adjusts the height to
maintain the amplitude constant. In this mode the contact time between tip and sample is
decreased and that reduces the possibility of sample damaging. By monitoring the phase
shift  between cantilever  oscillation  and  the  signal  sent  to  piezo  tube,  information  about
changes of viscoelastic properties of the material can be obtained.
The non-contact mode65 (Fig. 3.25) is also a dynamic mode where the cantilever
vibrates, but there is no direct contact between the tip and the surface. This enables
investigation of very soft and elastic materials because the force between cantilever and
sample is much smaller.
Fig. 3.25: AFM non-contact mode
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Different imaging modes enable broad range of application of AFM, starting from
observation of molecules, over analysis of membrane surfaces to imaging of living cells.
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Chapter 4: Materials
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4.1 PEG-based hydrogels
As matrix for the drug delivery system studied here a group of hydrogels based on
photopolymerized poly(ethylene glycol) diacrylate (PEGDA) was used. By varying the
molar mass of the PEGDA oligomers, networks can be prepared with varying average
molecular mesh sizes and chemical composition, which will affect the matrix swelling,
the drug-matrix interaction and consequently the drug diffusion and the drug release
rate66.
The initial substances were composed of acrylate derivatives of PEG, PEGDA 4000,
PEGDA 2000 and PEGDA 450. The numbers represent the number-averaged molecular
weight of the PEG chains before polymerization in g/mol. PEGDA oligomers possess
two photo-reactive sites and thus represent photopolymerizable materials (Fig. 4.1).
Hydrogel precursor solutions were formed by dissolving 5g of PEGDA in a 50/50
mixture of water and ethanol (10g) containing 50mg of photoinitiator 2-hydroxy-1-(4-(2-
hydroxyethoxy)phenyl)-2-methyl-1-propanone (Irgacure 2959).  Irgacure 2959 and
PEGDA 450 were obtained from Sigma-Aldrich, PEGDA 2000 and PEGDA 4000 were
provided by DSM.
O
O
nO
H2C
O
CH2
Fig. 4.1: Chemical structure of PEGDA oligomers
Photoplymerization was the method of choice to produce three-dimensional (3D)
polymer networks. It offers several advantages like fast curing rates (in the range from
seconds to minutes), low heat emission and in-situ applicability, which is important for
many biomedical applications67,68,69. The photopolymerization technique for hydrogel
formation assumes action of ultraviolet (UV) light on the precursor solution containing a
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photoinitiator70,71. The photoinitiator is a substance which is able by absorption of light to
undergo bond cleavage and create reactive free radical species. It is desirable that this
substance is biocompatible, water soluble and non-toxic. Radicals attack acrylate double
bonds and further promote photopolymerization reactions to create cross-linked
hydrogels.
Films of 0.12mm thickness were produced at DSM by curing on glass plates at 220C on a
conveyor belt fitted with a fusion BT13D D-bulb in an inert nitrogen atmosphere66. A UV
dose of 3 J/cm2 was determined using a UV Power Puck light meter. The chemical
conversion was determined by Attenuated Total Reflection Fourier Transform Infrared
(ATR FTIR) spectroscopy by measuring the peak intensity of the acrylate (C=O)-(CH)
bend vibration at 1408 cm-1 and the acrylate C=O stretch vibration at  1193 cm-1. It was
shown that the conversion of the acrylate double bonds on both sides of the film
(substrate and top) was above 98%.
The chemical structure of cross-linked PEGDA networks is shown in Fig. 4.2.
The mechanical properties of the hydrogels as well as the permeability for molecules
depend on the length of PEG segments between cross-links18.
O
O
O
OnOOO
O
O n O
O
O
OnO
O
Fig. 4.2: Chemical structure of the cross-linked PEGDA networks
Gels were obtained by immersing polymers into water. The cross-linked PEGDA films
were loaded with the drug according to the following procedure. Drug solutions in D2O
were prepared using 20mg of the drug and 1ml water. Then, the networks were loaded
with drug by mixing 50mg of the dry polymer with 1ml of the drug solution. The
Materials
66
resulting mixtures were left to stand for two days in order to reach the state of
equilibrium swelling. The samples always contained more water than required for the
equilibrium swelling.
4.2 Drug molecules
The water soluble drugs employed were proxyphylline [7-(2-hydroxypropyl)-1,3-
dimethylpurine-2,6 dione], flucloxacilline [sodium (2R, 5R, 6R)-6[[3-(2-chloro-6
fluorophenyl)-5methyl-oxaziole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-
azabicyclo [3.2.0]heptane-2-carboxylate] and the pseudo drug fluoresceine [disodium 2-
(3-oxido-6-oxo xanthan-9-yl)benzoate]. Flucloxacilline was obtained from DSM,
fluoresceine and proxyphylline were obtained from Sigma-Aldrich.
Proxyphylline (Fig. 4.3) is a water soluble derivative (water solubility 1000 g/l, MW 238
g/mol) of theophylline, a vasodilator. It acts on passages which supply lungs with air,
enables their relaxation and increased air flow. Therefore, this drug is very important in
treatment and prevention of bronchial astma and chronic bronchitis.
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Fig. 4.3: Proxyphylline chemical structure
The antibiotic flucloxacilline (Fig. 4.4) (water solubility 100 g/l, MW 454 g/mol) is used
in the treatment of bacterial infections. The bactericidal activity is based on its capability
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to inhibit the formation of bacterial cell walls. This is mediated through the proteins
located in the cell wall which have the affinity for penicillin binding.
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Fig. 4.4: Flucloxacilline chemical structure
The dye fluoresceine (Fig. 4.5) (water solubility 600 g/l, MW 376 g/mol) was chosen as
a model drug of comparable size to the other two. The sodium salt of fluoresceine is
called uranine and is used for dying materials and coloring agrochemicals and detergents.
The important application in biology is as fluorescence detecting agent, for labeling and
monitoring the molecules in various associations.
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Fig. 4.5: Fluoresceine chemical structure
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A water insoluble drug that was investigated is ibuprofen (Fig. 4.6) (MW 206
g/mol) [2-(4-isobutylphenol)propionic acid]. It is used for the relief of pain and fever and
for the suppression and treatment of inflammatory diseases. The Ibuprofen was purchased
from Sigma-Aldrich.
O
HO
Fig. 4.6: Ibuprofen chemical structure
Another investigated drug with poor solubility in water is amiodarone (Fig.  4.7)  (MW
682 g/mol) [(2-butylbenzofuran-3-yl)-[4-(2-diethylaminoethoxy)-3,5-diiodo-phenyl]-
methanone]. It is used in the form of the hydrochloride salt which is a white to slightly
yellow crystalline powder. Amiodarone is a very effective antiarrhythmic agent for
various forms of irregular heart beat (tachyarrhythmias). It is used in cases of life-
threatening heart rhythm disorders. Amiodarone was obtained from DSM.
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Fig. 4.7: Amiodarone chemical structure
All drugs were used as obtained and D2O was the solvent.
4.3 Cyclodextrins
Cyclodextrins (CDs) are cyclic oligosaccharides composed of glucopyranose units
linked  through  ?-1,4-linkages.  The  ?,  ? and  ? CDs  which  contain  six,  seven  and  eight
glucose units, respectively (Fig. 4.8), were obtained from Sigma-Aldrich.
Fig. 4.8: Chemical structure of ?, ? and ? cyclodextrins72
Materials
70
Topologically cyclodextrins are hollow toroids with one larger and one smaller opening
(Fig. 4.9). Such a structure enables them to build inclusion compounds with variously-
sized drug molecules (Sec. 2.4)73,74. Table 4.1 shows some important properties of
cyclodextrins75.
Fig. 4.9: Cone-shaped form of ? cyclodextrin
All drug-CD complexes with water soluble drugs were formed by mixing
equimolar amounts of drug and cyclodextrin. In the case of ? and ? CD, 20mg of drugs
was used. In the case of ? CD, the amount of drug was decreased to 8mg because of the
limited water solubility of ? cyclodextrin. The mixture of guest/host molar ratio 1/1 was
dissolved in 1ml D2O.
? CD ? CD ? CD
MW [g/mol] 972 1135 1297
Glucose
monomers
6 7 8
Internal cavity
diameter [?]
5.7 7.8 9.5
Water solubility
[g/100ml; 250C]
14.2 1.85 23.2
Table 4.1: Physical properties of cyclodextrins
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For the water insoluble drugs the molar fraction of the drug in the mixture with
cyclodextrin was larger than that of CD (for ibuprofen drug:CD molar ratio was 6:1 and
for amiodarone 2:1). The aim was to achieve high probability of drug encapsulation by
CD for poorly soluble drug molecules. The drug/CD mixtures were dissolved in 1ml
D2O. In the case of the amiodarone/CD mixture, for the solid-state NMR measurements
the amount of water was reduced to 0.3ml. After dissolution, the mixtures were strongly
stirred and left to stand for three days to achieve equilibrium. Then, the suspensions were
centrifuged and the clear drug-CD complex solutions were obtained.
The PEGDA matrices were also swollen in these complex solutions, according to the
above described procedure.
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Chapter 5: Experimental results and
discussion
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5.1 Properties of PEGDA matrices
5.1.1 AFM analysis of polymer surfaces
For coating applications of PEGDA polymers their surface properties will play an
important role. Although the surface properties of the PEGDA matrices seem to have no
direct relevance for the drug diffusion investigated in this thesis, the AFM results are
reported here, because they provide visual information about the effect of cross-linking
on  the  structure  of  the  matrix.  Cross-link  density  is  a  very  important  parameter  which
determines physical, chemical and mechanical properties of polymer films. By changing
the cross-link density of PEGDA networks the morphological properties of surfaces are
also changed. The change of the surfaces of PEGDA gels in response to the cross-linking
degree was examined.
The surface topography and morphology of these polymer films, as they were
polymerized on glass plates, were characterized by tapping mode atomic force
microscopy. The measurements were conducted in air under ambient conditions with the
AFM system provided by JPK Instruments. As cantilever a silicon tip with a spring
constant of 42 N/m and a resonance frequency of 320 kHz was used for all experiments.
Topographic (height mode) and viscoelastic (phase mode) images were recorded
simultaneously.
Recorded phase images provide information about changes in material properties, i.e. the
contrast in a phase image is related to the variation in sample surface stiffness76. Stiffer
regions  of  a  surface  induce  a  positive  phase  shift  and  therefore  appear  brighter  on  the
phase image. Darker regions of the phase image are assigned to the softer materials. The
higher the cross-link density, the higher is the stiffness of the material. It can be also
expected that at higher degrees of cross-linking, the domain structure will be reduced77.
The polymer surfaces were examined on various length scales (< 10 ?m).
The surface of the dry PEGDA 4000 matrix at room temperature is shown in the
Fig. 5.1. Both height and phase images are shown with the scan size of 10x10 ?m.
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Fig. 5.1: Height (left) and phase (right) AFM image of PEGDA 4000 matrix. The scan
size is 10x10 ?m
The figure shows a branched morphology with a pronounced ordering. Finger-like
patterns are observed revealing a fiber-like structure on the polymer surface. Fig. 5.2
represents the same sample on a smaller scale ( 2x2 ?m).
Fig. 5.2: Height (left) and phase (right) AFM image of PEGDA 4000 matrix. The scan
size is 2x2 ?m
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It clearly shows bundles of locally oriented fibers. The corresponding phase image
reveals stiffness variations even within a fiber. These images resemble morphological
features of crystallized poly(ethylene oxide) (PEO) adsorbed on a substrate78,79. This
phenomenon of molecular self-assembly in PEGDA 4000 polymer, resulting in finger-
like branched patterns, can be explained by the relative large length of PEG chains
between cross-links who tend to crystallize in thin films and close to interfaces. From the
AFM  pictures  the  average  width  of  the  fingers  is  about  100  nm  which  agrees  with  the
width of PEO fingers at room temperature found by Reiter et al.78.
When water is added, the polymer swells and this branched structure disappears. Fig. 5.3
shows the polymer gel surface of the same matrix after swelling in water. The image is
obtained by contact mode AFM. The gel surface exhibits a sponge-like pattern with large
holes among relative flat regions. Polymer swelling, therefore significantly changes
surface morphology and nanostructure of PEGDA films.
Fig. 5.3: Height image of swollen PEGDA 4000 polymer. The scan size is 5x5 ?m
Fig. 5.4 represents the surface of the dry PEGDA 2000 matrix at 10x10 ?m length
scale. A problem that appears at higher cross-link densities is volume shrinkage during
the curing process. As a consequence this leads to formation of voids and cracks in the
polymer.
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Fig. 5.4: Height (left) and phase (right) AFM image of PEGDA 2000 matrix. The scan
size is 10x10 ?m
The surface fractures in the case of PEGDA 2000 film are visible in the AFM images.
The height variations are very large and the dark regions in the height image (lower in
height) correspond to the stiffer domains in the phase image. They probably display the
surface of the glass plate between the higher and softer polymer domains. Due to that it
was not possible for this matrix to observe fine features on the polymer surface itself and
to characterize its nanostructure.
The  morphology  of  the  PEGDA  450  surface  is  shown  in  the  Fig.  5.5  at  two
different length scales. Shrinkage occurred also in this case, but it was possible to observe
and characterize small parts of the polymer surface free of cracks. The surface
morphology is flat and uniform in their viscoelastic properties, which is desirable for
polymer coatings applications. Small bright particles in the height image at some parts of
the polymer sample probably appear due to air between the polymer surface and the glass
plate. In agreement with that is the finding from the phase image that these particles are
softer than the rest of the polymer.
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Fig. 5.5: Height (left) and phase (right) AFM images of PEGDA 450 matrix. The scan
size is 10x10 ?m
The AFM images of PEGDA polymers clearly show that the cross-link density
significantly affects the topography and morphology of the polymer network surface.
There  is  a  tendency  that  with  increasing  cross-link  density  the  domains  on  the  surface
become smaller in size. The PEGDA 2000 matrix represents an exception because its
surface structure could not be characterized. A comparison between PEGDA 4000 and
PEGDA 450 surfaces reveals that the higher the cross-link density the smoother the
surface. The surface changes appreciably, when the polymer swells in the presence of a
solvent.
The surface studies make clear that cross-linking and swelling are important
factors for the designing of coatings.
5.1.2 Binary water/polymer systems – swelling behavior
The investigation of the drug delivery systems started with the two-component
system  consisting  of  water  (D2O) and cross-linked poly(ethylene glycol) diacrylate
polymers of different cross-link densities:  PEGDA 4000, PEGDA 2000 and PEGDA
450. For each network the swelling behavior was determined by measuring the proton
NMR spectrum as a function of the water content. All NMR experiments are carried out
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in 5 mm NMR tubes on a Bruker DRX 500 MHz spectrometer. To the dry cross-linked
polymer D2O was added in small steps. After every step the sample was left to stand for
48h in order to reach equilibrium and then the proton spectrum was recorded (Fig. 5.6).
At first only a broad polymer line was observed. When the water-polymer equilibrium
swelling composition was approached, the polymer line narrowed and a water peak (from
HDO) at approximately 4.8 ppm showed up. When the amount of added water surpassed
the amount given by the maximum water uptake of the network (maximum swelling), a
second water peak, slightly narrower and downfield from the first peak showed up as
shown for the case of PEGDA 450 in Fig. 5.6.
Fig. 5.6: NMR spectra of the PEGDA 450 matrix at different amounts of swelling water
Experimental results and discussion
79
The amount of water absorbed by the sample just before the second water peak appeared
is the maximum swelling amount of the hydrogel. When we define a swelling factor, sw,
as the ratio of the water weight at maximum swelling and the dry polymer weight, then
the swelling factors are 4.0 (PEGDA 450), 6.0 (PEGDA 2000) and 10.0 (PEGDA 4000)
(Table 1).
The average mesh size of a network, ?, can be related to the swelling factor of the
sample26 as already shown in Chapter 2:
32
0 swr ???     ,                                                  5.1
where 20r , representing the average end-to-end distance of the polymer chains
between cross-links in the absence of swelling water, depends on the number-average
molecular mass of the chains in the network between cross-links, Mc26:
r
c
n M
M
Clr ???? 220    ,                                              5.2
where  l  is  the  bond  length  (taken  as  1.5  ?),  Mr is the molecular mass of the polymer
repeating unit (44 g/mol) and Cn is the characteristic ratio for PEG (=4.0)80. The
molecular weight between cross-links, Mc, was calculated using the Flory equation24.
This equation was later applied by Lu and Anseth81 for evaluation of Mc values in PEG-
based networks:
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  ,                                5.3
where Mn is the number-average molecular weight of the polymer before cross-linking, ?2
the polymer volume fraction in the swollen gel, V1 the  molar  volume of  the  water  (18
cm3/mol at room temperature), ?  the specific volume of the polymer, and ? the Flory-
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Huggins polymer-solvent interaction parameter82.  The  calculated  values  of  the  Mc,
average end-to-end distances and mesh-sizes are shown in the Table 5.1
Table 5.1 Calculated network parameters
network
Mc
(g/mol)
2
0r  (Å) sw= polymerdryweight
swellingatwaterweight .max
?  (Å)
PEGDA4000 1700 26.4 10.0 57
PEGDA2000 702 17.0 6.0 31
PEGDA 450 186 8.8 4.0 14
The accuracy of the average end-to-end distance for the PEGDA 450 network is not high,
because it is questionable whether eq. 5.1 can be applied for a network with such a small
Mc value17. The value of the mesh size ? for this network should therefore be taken as an
order of magnitude estimate, but it shows that in the PEGDA 450 network, the mesh size
is of the same order of magnitude as the size of the largest drug molecule.
When  the  amount  of  added  water  surpasses  the  maximum  swelling  amount,  a
water phase coexists with a hydrogel phase. All samples investigated later always
contained more water than the polymer can take up by swelling. Therefore, each sample
was a two-phase system composed of a water phase and a gel phase in equilibrium. Fig.
5.7 shows the proton NMR spectra of the swollen networks. Beside the water peak at 4.8
ppm, there is an additional line somewhat broader and slightly shifted upfield. This line
arises from the water in the gel phase of these systems. The two water peaks represent the
two different populations of water molecules, “free water” in the water phase and “gel
water”. A similar observation for hydrogels with high water contents was made by
Calderara et al83.  It  can  be  observed  that  when  the  cross-link  density  of  the  matrix
increases, the chemical shift difference between the two water populations also increases.
The broad line at 3.7 ppm in the spectrum of Fig. 5.7 is the polymer line from PEG
protons. The narrow line on the top of the broad polymer line arises from PEG chains
which possess a higher mobility. They either are not part of the cross-linked network or
arise from PEG dangling ends18.  The  acrylate  CH2 protons were not observed because
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these parts of the network apparently have a higher rigidity and escape observation with
the NMR spectrometer set up for high resolution liquid state NMR on static samples. As
the  cross-link  density  increases,  the  polymer  network  becomes  more  rigid  and  the  PEG
chains become less mobile which causes the broadening of the associated NMR polymer
resonance peak.
Fig. 5.7: 1H NMR spectra of swollen PEGDA networks (50 mg polymer, 1 mL water)
5.2 Water/drug/polymer ternary systems
In order to study drug mobility in the gel as well as drug-matrix interaction, three-
component systems (ternary systems) composed of polymer, drug and water were
prepared. Composition of the mixture was the same for each type of the cross-linked
network (1mL D2O, 50 mg polymer and 20mg drug). The proton NMR spectra of the
three (model) drug molecules, flucloxacilline, fluoresceine and proxyphylline were
monitored in D2O solution and in water-polymer mixtures. As an example Fig. 5.8 shows
Experimental results and discussion
82
the 1H NMR spectra of flucloxacilline in water and in swollen matrices. The
corresponding spectra of proxyphylline and fluoresceine are described in Appendix 9.1.
Water and the polymer in these ternary systems exhibit the same behavior as in the binary
polymer/water systems.
Fig. 5.8: 1H NMR spectra of flucloxacilline in water solution (a), in PEGDA 4000 (b), in
PEGDA 2000 (c), and in PEGDA 450 (d).
In order to extract more information about the drug behavior in the swollen gels, the 1H
NMR spectra of the aromatic protons of flucloxacilline at 7-8 ppm are shown in Fig. 5.9.
The water solution spectrum of the drug is shown in Fig. 5.9 a, the spectra of the drug in
the drug-polymer-D2O mixtures in Fig. 5.9 b-d. In the spectra of the ternary system every
drug line consists of two components, just as observed for water in Fig. 5.7. Beside the
drug  lines  at  the  same  chemical  shift  as  for  the  drug  in  the  water,  there  are  additional
lines. Fig. 5.9 indicates that, as expected for a water-hydrogel two-phase system, the drug
molecules partition between the water phase and the hydrogel phase. In the water phase
of such a system the NMR spectrum of the drug shows the same J-multiplets as in
solution, but the lines are somewhat broader. To each J-multiplet in the spectrum belongs
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a much broader line shifted to low-field of which the J-coupling multiplet structure is no
longer visible. These broader lines represent the drug population in the hydrogel phase.
With increasing cross-link density the chemical shift difference, waterdrug
gel
drug ?? ? , between
these two populations increases (see also Table 5.2).
Fig. 5.9: 1H NMR spectra of the aromatic region of flucloxacilline in water solution (a),
in PEGDA 4000 (b), in PEGDA 2000 (c) and in PEGDA 450 (d).
The signals from the drug in the hydrogel phase become also broader with increasing
cross-link density. A noteworthy observation is that the effect of the network on the
chemical shift for water (upfield shift) is opposite to that of the drugs (downfield shift for
most of the protons of the three drugs). For flucloxacilline the network effect differs even
for  different  kinds  of  protons  in  the  drug.  That  proves  that  the  shifts  are  not  due  to
magnetic susceptibility differences between the gel and the water phase.
For all drugs the shift, waterdrug
gel
drug ?? ? , doubles when going from PEGDA 4000 (calculated
mesh size 57 ?) to PEGDA 450 (calculated mesh size 14 ?). Table 5.2 shows how the
chemical shift difference changes for different drugs in different matrices.
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Table 5.2 waterdrug
gel
drug ?? ?  for drug aromatic protons for all drug-polymer combinations; the
                accuracy of these values is approximately 0.004 ppm.
water
drug
gel
drug ?? ? in ppm
Proxyphilline
(7.95 ppm)
Fluoresceine
(7.8 ppm)
Flucloxacilline
(7.8-7.2 ppm)
PEGDA 4000 0.020 0.081 0.046
PEGDA 2000 0.033 0.132 0.070
PEGDA 450 0.040 0.166 0.101
The fact that this shift depends on the network cross-link density, and that it is so small,
means  that  the  drug  molecules  in  the  gel  are  not  simply  permanently  adhered  to  a
polymer chain in the network. The situation must be very similar to that of the binding of
a ligand to a macromolecule, where the ligand exchanges between free in solution and a
position bound to the macromolecule84.
Proton NMR spectra of fluoresceine and proxyphylline in the swollen matrices exhibit
the same behavior, the lines of the drug in the water phase are accompanied by additional
lines arising from drug molecules present in the gel phase of the two-phase systems.
5.3 Lateral mobility (self-diffusion)
The  self-diffusion  coefficients  of  the  three  drug  molecules  and  of  water  are
determined by 1H  PFGE  NMR  under  the  same  equilibrium  conditions  as  used  for  the
spectra in Fig. 5.7-5.9, that is with so much water that the water-polymer system is a two-
phase system and the gel is maximally swollen. As shown above, the resonances of drug
(and water) in the water phase are shifted from the resonances of the drug (and water) in
the gel phase. That allows the measurement of drug/water self-diffusion coefficients in
both phases in the same experiment.
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The self-diffusion coefficients were measured by the Pulsed Field Gradient Echo NMR
technique and evaluated using the Stejskal-Tanner procedure53. The pulse sequences
employed were the Hahn-echo for the proxyphylline and flucloxacilline self-diffusion
measurements, and the stimulated-echo for fluoresceine. In the case of fluoresceine, the
Hahn-echo technique could not be applied due to the short T2 time of the aromatic
protons of this drug. All measurements were performed by keeping the pulse duration
time ? (1 ms) and diffusion time ? (20 ms) constant during the experiment and by
varying the magnitude of the field gradient (0-500 G/cm).
5.3.1 Deconvolution of the spectra
In some cases, especially with the PEGDA 4000 matrix, the NMR drug lines of
the drug in the gel phase and in the water phase overlap. For these cases the WinFit
software is used to deconvolute the composite line. Overlapping signals are fitted with
two lines, each a mixture of Gaussian and Lorentzian line types. The Gaussian and
Lorentzian contributions were varied for each line or group of lines until optimal
agreement with the experimental data is achieved. Fig. 5.10 shows the lines of
proxyphylline in the swollen PEGDA 4000 matrix at T= 22 0C. The green and the violet
line represent two deconvoluted component lines whose sum (red line) corresponds to the
shape of the proxyphylline overlapping peaks (blue spectrum). After deconvolution the
separate lines could be integrated to obtain the spin-echo intensity. In the case of PEGDA
4000 matrix the deconvolution was necessarily performed for each investigated drug
molecule.
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Fig. 5.10: Deconvolution of two proxyphylline lines in PEGDA 4000 matrix
For  the  determination  of  the  drug  and  water  self-diffusion  coefficients  two
methods were used. In the first method the lines for the drug in the water and in the gel
are first separated. The self-diffusion coefficient D for each of the two lines can be then
obtained by exponential fitting of the data using eq. 3.19, or by calculating the negative
slope of the logarithmic Stejskal-Tanner plot. In this study the average value of the
diffusion coefficients obtained by these two fits is employed. Fig. 5.11 shows the PFGE
decay curves for the proxyphylline/PEGDA 450 system at 22 0C when the behavior of the
two lines (drug in gel and drug in water) is separately analyzed. The blue lines are related
to the drug in the water phase and the red lines represent the drug in the gel phase. In the
diagram  a,  the  linear  fits  of  both  components  are  shown  and  the  diagrams  b  and  c
represent the exponential decays for the two components. The average values for this
system are for the drug in the water ? ? smD waterdrug /1006.084.4 210???? , and for the drug in
the gel ? ? smD geldrug /1002.054.0 210???? .
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Fig. 5.11: PFGE decay curves for the proxyphylline/PEGDA 450 system at 22 0C
after deconvolution of the two overlapping lines.
In the second method the intensity of both lines are integrated and plotted against G2. Fig.
5.12 shows the biexponential fit of the same system as described above. This curve
results when the integral of both lines is plotted and biexponentially fitted.
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Fig. 5.12: PFGE decay curves for the proxyphylline/PEGDA 450 system at 22 0C
when the behavior of the two components together is analyzed.
Experimental results and discussion
88
The diffusion coefficients obtained with this method are
? ? smD waterdrug /1006.099.4 210???? and ? ? smD geldrug /1002.054.0 210???? . For this
drug/matrix system there are no significant differences between these two methods. The
second method is very accurate when the self-diffusion coefficients are sufficiently
different. The first method is preferred when not.  For all drugs in the PEGDA 4000
matrix the first method was applied. This is the lowest cross-linked network which affects
the drug self-diffusion in the gel much less than the other matrices and therefore the
differences between two drug components are not big enough that the biexponential fit
can be applied. Also, proxyphylline was the only drug where the first method was
preferred  for  all  PEGDA matrices  because  this  drug  is  smaller  than  the  other  ones  and
therefore is less influenced by the network.
5.3.2 Effect of the network on the self-diffusion
The self-diffusion coefficients of flucloxacilline, fluoresceine, and proxyphylline
were measured using the signals at 2.7 ppm (CH3), 7.6 ppm, and 8 ppm (aromatic
protons), respectively at three different temperatures (12, 22, and 37 0C). The diffusivity
data for every drug-polymer network combination at the three temperatures are shown in
Table  5.3.  The  existence  of  different  self-diffusion  coefficients  and  chemical  shifts  for
drug and water molecules in the water and gel phase proves that water and drug do not
exchange fast between the water and gel phase during the time scale of the experiments.
This  implies  that  the  water  and  gel  phase  domains  have  sizes  far  greater  than  the
nanometer scale. This agrees with the system used, which consists of mm-sized polymer
films separated by water/drug solution.
The drug diffusion in the water phase should be independent of the cross-link density of
the gel phase. Table 5.3 shows that the drug-diffusion coefficient in the water phase of
the PEGDA 4000 gel clearly deviates from the corresponding values for PEGDA 2000
and PEGDA 450 matrices. This is not due to a measurement error, but due to a slow
exchange of the drug between the water and the gel phase of PEGDA 4000.
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Table 5.3 The drug and water self-diffusion coefficients (in 10-10 m2/s) at three different
temperatures and the corresponding diffusion activation energies (in kJ/mol) for all three
networks. The average experimental error of the diffusion values is estimated to be less
than ?5%, for the activation energies the maximum error is ?10%.
Drug Proxyphilline Fluoresceine Flucloxacilline
T in oC 12 22 37 EA 12 22 37 EA 12 22 37 EA
PEGDA 4000
gel
drugD 1.5 2.0 2.7 17 1.0 1.3 1.7 15 1.2 1.6 2.1 17
water
drugD 2.7 4.0 5.8 23 1.8 2.7 3.8 21 2.6 3.8 5.3 21
gel
HDOD 9.4 13.2 17.5 18.3  10.2 12.9 17.3 16
water
HDOD 13.7 18.3 26.5 20  13.4 17.9 26.9 21
PEGDA 2000
gel
drugD 1.0 1.3 1.8 19 0.4 0.5 0.7 18 0.3 0.4 0.6 18
water
drugD 3.4 4.5 6.7 20 2.2 3.2 4.6 21 2.6 3.6 5.3 21
gel
HDOD 7.0 9.6 12.8 19 7.2 9.3 13.1 18 7.1 9.3 13.0 18
water
HDOD 13.2 18.7 25.5 20 13.2 18.0 26.0 20 13.5 18.6 26.5 20
PEGDA 450
gel
drugD 0.4 0.5 0.7 15 0.1 0.1 0.2 14 0.1 0.1 0.1 14
water
drugD 3.4 4.9 6.8 20 2.3 3.1 4.6 21 2.6 3.7 5.2 21
gel
HDOD 4.3 6.0 8.1 19 4.5 6.0 8.6 19 4.3 5.9 8.0 18
water
HDOD 13.2 19.1 25.7 20 12.8 17.7 24.9 20 13.4 18.3 25.7 19
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The mobility of the drug in the other networks is lower and such exchange is not noticed
for these cases. The water diffusion coefficient in the system composed of PEGDA 4000
and fluoresceine could not accurately be determined in the same experiment due to the
large gradient strength that was needed for the fluoresceine diffusion.
The diffusivity of the drug molecules in the hydrogel changes when the cross-link
density, or the average PEG chain length between cross-links, of the polymer matrix is
changed. With increasing cross-link density, from PEGDA 4000 to PEGDA 450, the self-
diffusion coefficients of the drugs in the hydrogel decrease and the difference between
diffusion  rates  of  the  drugs  in  the  water  phase  and  in  the  gel  phase  becomes  more
pronounced. Some of the data of Table 5.3 can be represented in a different way. A good
impression of the effect of the gel network density (mesh size) on the diffusivity is
obtained when the relative diffusion coefficients waterdrug
gel
drug DD /  are calculated (Fig. 5.13).
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Fig. 5.13: Dependence of the relative drug diffusion coefficients on the polymer mesh
size. The temperature averaged values are shown.
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This  representation  shows  that  the  polymer  network  has  the  greatest  effect  on  the
diffusion of the largest drug molecule (flucloxacilline with MW 494 g/mol) and the
smallest effect on the smallest drug (proxyphylline with MW 238 g/mol). For the network
with the largest mesh size (PEGDA 4000) the drug size has little or no effect on the
relative drug diffusivity. At the intermediate cross-link density (PEGDA 2000) the effect
of the network on the drug diffusion is dependent on the drug molecular size. The mesh
size apparently becomes small enough to affect the diffusion of all three drugs in a
considerable way. For PEGDA 450, where the mesh size is of the same order of
magnitude as the drug size, the drug size does not play an important role any more.
The quantitative values representing the network effect on the drug and water diffusion
are shown in the Table 5.4.
Table 5.4 Relative drug diffusion coefficients waterdrug
gel
drug DD /  for all drug/PEGDA
combinations and waterHDO
gel
HDO DD /  for HDO in the gel and water phase.
water
drug
gel
drug DD /
water
HDO
gel
HDO DD /
2
2
2
1
1
???
?
???
?
?
?
?
?
PEGDA Proxyphilline
MW 238
Fluoresceine
MW 376
Flucloxacilline
MW494
HDO
4000 0.42 0.41 0.44 0.70 0.67
2000 0.29 0.16 0.11 0.52 0.50
450 0.12 0.05 0.03 0.32 0.36
The effect of the temperature on these values is smaller than the error in the values, therefore the
temperature averaged values are given. The values for HDO are independent of the dissolved drug. In the
last column the calculated values of the factor of eq. 2.32 are shown where ?2 is the volume fraction of the
polymer in the hydrogel.
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Table 5.4 shows that the network slows down the drug diffusion in the gel relative to the
drug diffusion in water. The smaller the drug, the less hindered its diffusion in the
hydrogel.
With increasing cross-link density, also the rate of water diffusion decreases. The effect
of the network on the water self-diffusion is smaller than on the drug diffusion. Actually,
as Table 5.4 shows, the effect of the matrix on the diffusion of the small water molecules
can be well described by the lattice model of eq. 2.32. The measurements also show that
the diffusion of water in the hydrogel is not affected by the type of drug in the hydrogel,
at least at drug concentrations that are used here.
5.3.3 Temperature dependence of diffusion and activation energies
Drug and water self-diffusion measurements for each combination drug-polymer
matrix were performed in the temperature range between 12 and 37 0C. As the
temperature increases the drug diffusion becomes faster, both for the population in the
polymer network (the hydrogel phase) and for the population in the water phase.
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Fig. 5.14: The PFGE decay of proxyphylline peaks at 8 ppm in PEGDA 2000 matrix at
12 0C (a), 22 0C (b) and 37 0C (c). The gradient increases from the top to bottom
spectrum
Fig. 5.14 shows the intensity decay of proxyphylline resonance peaks in the PEGDA
2000 matrix with increasing gradient strength at three different temperatures. In each of
these three spectra a clear difference between the two components can be observed. The
left peak whose decay is slower corresponds to the drug in the gel phase (with the lower
diffusion coefficient). The right peak has a shorter decay and corresponds to the drug
component in the water phase which diffuses faster. When the spectra at different
temperatures are compared, it can be clearly seen that for each of the two components the
decay becomes faster with increasing the temperature. This means that the diffusion
becomes faster in both phases.
Diffusion through the polymer network can be interpreted as an activated process
and the temperature dependence of the diffusion coefficient was fitted with an Arrhenius-
type equation:
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? ?RTEaeDD /0
???   ,                                                    (5.4)
D0 represents the diffusivity at infinite temperature, T the absolute temperature, and Ea
the activation energy. Fig. 5.15 presents the Arrhenius plots for flucloxacilline in
different cross-linked networks. The same plots for proxyphylline and fluoresceine are
shown  in  Appendix  9.2.  The  Arrhenius  plots  of  diffusivities  are  linear  over  the
temperature range 12-37 0C and from the slopes of these plots activation energies both for
the drug and water diffusion were determined. The values of activation energies are given
in the Table 5.3. Because the curves in Fig. 5.15 are parallel, it can be concluded that the
activation energies are independent of the phase in these two-phase systems and also
independent of the polymer cross-link density. The values of Ea are comparable to the
hydrogen bonding energy of water. This will be explained in more details in the next
Chapter about diffusion model.
It is acknowledged that the temperature range is rather small and therefore the measured
activation energies represent the value of –R(?(lnD)/?(1/T)) in the middle of the studied
temperature range.
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Fig. 5.15: Arrhenius plots of ln(D) of flucloxacilline versus the reciprocal of the absolute
temperature in different matrices (PEGDA 4000-black lines, PEGDA 2000-blue lines and
PEGDA 450-red lines). The three overlapping dashed lines represent the drug diffusion
in the water phase, the solid lines in the gel phase.
5.4 Rotational mobility (rotational diffusion)
Self-diffusion coefficients give information about the translational diffusion
motion  of  molecules.  Rotational  diffusion  motions  can  be  investigated  by  NMR
relaxation measurements. The drug mobility in two different phases of the swollen
polymer systems (free water and gel) can be specified by measuring T1 and T2 relaxation
times.  A  molecular  system  for  which  the  spin-lattice  relaxation  time  T1 approximately
equals the spin-spin relaxation time T2, executes an isotropic rotational motion. For a
rigid molecular system or a system that exhibits strongly anisotropic rotational motions
T2 will be much shorter than T1.
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To investigate the rotational mobility of the drug molecules in the hydrogel matrices, the
T1 and  T2 relaxation times were measured for two drug molecules, proxyphylline and
flucloxacilline,  in  the  PEGDA  matrices  of  different  cross-link  density.  The  spin-
relaxation time (T1) was measured by the inversion recovery method (Chapter 3). The
intensity of the NMR signal is measured for different time intervals between the two
pulses, and then fitted with the eq. 3.12. Fig. 5.16 presents the evaluation of the T1 for
flucloxacilline in PEGDA 2000 matrix at 25 0C.
Fig. 5.16: Measurement of the T1 time via the inversion recovery method for the
flucloxacilline/PEGDA 2000 system at T=25 0C. The change of the peak intensity with
the time ? between the pulses is shown and fitted with the single exponential.
The total signal intensity of both water and gel drug components is measured and as Fig.
5.16  shows  there  are  no  significant  differences  in  T1 times  between  the  two  drug
populations. The average T1 time for  this  system is  2.2  s.  For  the  determination  of  the
spin-spin relaxation time (T2), the spin-echo technique is used (Chapter 3). In this case
the echo attenuation is measured for different time intervals between the pulses and the
results are fitted with eq. 3.13 (Fig. 5.17). Fig. 5.17 shows that two components with
different T2 relaxation times exist.
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Fig. 5.17: Measurement of the T2 time with the spin-echo technique for the
flucloxacilline/PEGDA 2000 system at T=25 0C. The decrease of the signal intensity with
the time ? between the pulses is shown and fitted with a double-exponential function.
The longer relaxation time (in this case 1.02 s) corresponds to the drug in the water phase
and the shorter T2 time (in this case 0.19 s) to the drug in the hydrogel. The measured
relaxation  times  for  all  systems are  shown in  the  Table  5.5.  For  the  drugs  in  the  water
phase T2 is only about 50% shorter than T1, indicating that the rotational tumbling motion
of the drug molecule in the water phase is almost isotropic. Changing from the water
phase to the gel, the drug T2 becomes 4-5 times smaller, whereas the T1 is not
significantly affected. For each drug molecule (with one exception) the relaxation times
in the gel do not change by varying the cross-link density of the network. The exception
is for the biggest drug molecule flucloxacilline (M=494 g/mol) for which in the highest
cross-linked network, PEGDA 450, the T2 time decreases by a factor 3 relative to T2 in
the other networks. This confirms that the drug size in this case approaches the pore size
of the network and the tumbling motion becomes much more hindered.
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Table 5.5 T1 and  T2 relaxation times of drug molecules at 25 0C; the average error is
about ? 10%.
Proxyphylline Flucloxacilline
T1 [s] T2 [s] T1 [s] T2 [s]
PEGDA 4000
water 0.98 0.9
hydrogel 2.2 0.22 1.8 0.23
PEGDA 2000
water 1.3 1.02
hydrogel 2.6 0.29 2.2 0.19
PEGDA 450
water 1.4 0.97
hydrogel 2.6 0.24 1.6 0.076
In order to develop a model for the anisotropic rotational motion of the drug
molecules, the drug molecule is described as a rigid flat disc with axial symmetry (Fig.
5.18).
R1 R2
R3
Fig. 5.18: The axially symmetric molecule with its axes of rotation
It can be expected that the rotational motion of such a disc about different axes occurs at
different rates. R1 is defined as the rotational diffusion rate around the symmetry axis
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perpendicular to the plane and R2 is the rotational diffusion rate around the in-plane axis.
It  is  assumed  that  rotations  around  the  two  in-plane  axes  occur  at  equal  rates  (R2=R3).
Thus, for a description of the rotation of axially symmetric molecules two rotational
correlation times are sufficient.
The anisotropy effects can be better understood if the relaxation times for various
ratios  R1/R2 are known. By programming the equations developed by Woessner42 in
Mathematica 4.1, a qualitative picture of the relaxation rates for various ratios R1/R2 can
be obtained (Fig. 5.19).
0
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1 ´ 1010
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T1/T2
Fig. 5.19: T1 and T2 relaxation times with respect to the rotational diffusion rates about
the two molecular axes, R1 and R2. Rotational rates are given in s-1.
In this 3D plot the upper surface represents the T1 values and the lower one the T2. From
this plot it can be concluded that the motion of the free drug molecules in the water phase
of the PEGDA systems correspond to the situation in the upper right hand corner of the
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surface (R1 and R2 both fast), where T2?T1. The situation of drugs in the gel corresponds
to the lower right hand corner of the figure 5.19 (R1 still fast but R2 much slower) where
T2<<T1. This would mean that the rotational motion of the drug around the axis
perpendicular to the plane (R1) is not very much affected by the network, in contrast to
the rotational motion around the in-plane axis (R2).
The cross-section of the plot at the constant rotation rate R1 about the symmetry axis (Fig.
5.20), corresponds to the transition of the drug from the water to the gel phase. Fig. 5.20
nicely shows how by changing to the hydrogel phase the tumbling motion (R2) becomes
significantly slower.
1 ´ 109 2 ´ 109 3 ´ 109 4 ´ 109 5 ´ 109
R2
2
4
6
8
10
T1?T2 R1=8* 109
water phasegel phase
T1/ 2
Fig. 5.20: Cross-section of the 3D plot at the constant rotation rate around the symmetry
axis (R1= 8?109). The upper curve corresponds to the T1 and the lower curve to the T2
relaxation time. Rotational rates are given in s-1.
In the gel the motion of the drug molecules exhibits a large anisotropy, where the rotation
around the in-plane axis is drastically slower than the rotation around the symmetry axis.
This is caused by the fact that for the tumbling motion molecules need more energy and
the energy barrier for such a motion in the gel is higher.
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A similar phenomenon is found for benzene. Molecular dynamics simulations on the
benzene molecule in benzene liquid43 show that the rotation about the C6 axis (spinning
motion) is faster than the rotations about the in-plane axes (tumbling motion). By
introducing the benzene in a polymeric matrix, the tumbling motion is drastically slowed
down, whereas the rotation about the symmetry axis is only slightly affected.
The study of the drug rotational mobility shows that the rotational diffusion around the
symmetry axis is not very much sensitive to the environment, but the rotational diffusion
around the in-plane axis becomes strongly affected by changing from the water to the gel
phase.
5.5 Drug-matrix interaction
As shown previously, for all three drugs the NMR resonances of the drug in the
gel are shifted and broadened relative to the corresponding lines of the drug in the water
phase. The higher the cross-link density, the higher the shift and the broadening are.
Thus, also the shift and broadening (in addition to the self-diffusion and T2 experiments)
prove the existence of an interaction between the drug molecule and the network.
Not only the proton NMR chemical shifts serve as evidence that the drug
molecules interact with the polymer network. Two NOE methods are used to confirm this
finding. In the STD experiment, the on-resonance spectrum is obtained by saturation of
polymer resonances in a region where no drug peaks are present (at 3.75 ppm). The off-
resonance spectrum (reference spectrum) is obtained by saturation far away from both the
drug and the polymer lines. Fig. 5.21 presents the STD NMR experiment on the
proxyphylline/PEGDA 450 system. In Fig. 5.21a the black spectrum represents the
reference spectrum and the red one is the on-resonance spectrum. By selective saturation
of the polymer the signal intensity of the drug population in the gel phase decreases. The
transfer  of  saturation  from  the  polymer  to  the  drug  can  only  occur  during  the  time  the
drug is very near (distance smaller than approximately 0.5nm) the polymer network.
Therefore, the difference spectrum in the Fig. 5.21b contains only the peaks from the
drug molecules which are that close to protons of the matrix. This shows that the drug
molecules in the gel phase possess some binding affinity for the PEGDA matrix.
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Fig. 5.21: STD NMR experiment for the proxyphylline/PEGDA 450 system. Off-
resonance (black) and on-resonance (red) spectra (a) and the difference spectrum (b)
The second NOE method, also for detection of possible drug-matrix interactions is the 2D
NOESY technique. The appearance of cross-peaks in the 2D NMR proton spectrum
confirms the proximity between the corresponding protons. Fig. 5.22 presents NOESY
spectra of the flucloxacilline/PEGDA 2000 and flucloxacilline/PEGDA 450 systems.
Beside the cross-peaks arising from the protons in one molecule (intramolecular) or from
interaction with water, there are additional cross-peaks. These are intermolecular cross-
peaks which connect the drug protons with the polymer protons in the spectrum. This is
also evidence for the existence of interaction between the drug molecules and the
PEGDA matrices.
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a)
b)
Fig. 5.22: 2D NOESY spectra of the flucloxacilline/PEGDA 2000 (a) and the
flucloxacilline/PEGDA 450 (b) system. Mixing time was 2 s.
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Although the drug molecules in the gel interact with the PEGDA polymers, the
fact that the chemical shift in the gel phase depends on the network cross-link density,
and that the shifts are so small implies that the drug molecules are not permanently
attached to a polymer chain in the network. This is also confirmed by the non-zero
diffusion coefficient in the gel geldrugD . Behavior of the drugs in the hydrogel resembles the
behavior of a ligand that exchanges between bound to a receptor and the free in solution
state. The exact model describing the drug-matrix interaction will be presented in the
Chapter 6.
5.6 Drug-cyclodextrin complexation
Another type of drug carrying devices very important in drug delivery is
represented by the class of cyclic oligosaccharides known as cyclodextrins. Cyclodextrins
(CDs) are used as solubilizing agents to enhance drug solubility both in solutions and in
swellable polymers, as well as to protect drugs from attack by various species85. Binding
of drugs to cyclodextrins occurs via (partly) encapsulation of the drug in the inner
hydrophobic cavity of a cyclodextrin.
NMR is a widely used approach to study inclusion complexation. As evidence of
complex formation serve changes in the proton NMR chemical shifts of both species
(drug and cyclodextrin) involved in the complexation. The magnitude of this change, ??,
is defined as a difference between the chemical shift of a proton in the pure compound
and the chemical shift of that proton in the presence of the other substance. This change
of the chemical shift ?? depends on the location of the proton in the molecule, size of the
CD cavity and the host/guest ratio86. The 1H NMR chemical shift range of CDs is rather
narrow, between 3.5 and 4.1 ppm. H-3 and H-5 CD protons are external protons and
appear approximately in the region 3.8-4.1 ppm. H-2 and H-4 protons are located inside
the cavity and their signals are expected between 3.6 and 3.7 ppm. The structural
assignment of different cyclodextrin protons is given in the Appendix 9.3. Inclusion of
the aromatic drug usually causes upfield shifts of the internal cyclodextrin protons. The
resonances of the aromatic drug due to complexation are generally shifted
downfield87,88,89.  In  this  section,  the  interaction  between  some  water  soluble  and  water
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insoluble drug molecules and different kinds of cyclodextrins (?, ?, and ?) has been
investigated.
5.6.1 Complexation of water soluble drugs
For the water soluble drugs the drug and CD concentrations were chosen in a way
that the guest/host molar ratio was approximately 1:1. In the 1H NMR spectrum of ? CD
in D2O (Fig. 5.23a) the signals of external protons are found at ca. 3.65 ppm for H-2 and
at ca. 3.60 ppm for H-4. The signals of protons attached to the interior of the cavity are
found at ca. 4.0 ppm for H-3 and at ca 3.89 ppm for H-5 protons. After adding the
flucloxacilline (Fig. 5.23) the complexation resulted in an upfield shift of the inner H-3
protons and at the same time in a slight downfield shift of the drug protons. The
resonances of external protons (H-2, H-4) remained unchanged.
a)
3.63.73.83.94.04.14.2 ppm
alpha CD
alpha CD +
flucloxacilline
flucloxacilline
external protons
inner protons
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b)
7.27.37.47.57.67.7 ppm
alpha CD
alpha CD +
flucloxacilline
flucloxacilline
Fig. 5.23: 1H NMR spectra of ? CD and flucloxacilline in D2O solution. Fig. 5.23a shows
the CD spectral region and Fig 5.23b the aromatic spectral region.
Fluoresceine exhibits similar behavior except that the upfield shift of the H-3 and also H-
5 protons is more pronounced. Additionally, an upfield shift of the external protons, H-2
and H-4, can be observed. (Fig. 5.24).
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3.63.73.83.94.04.14.2 ppm
alpha CD
alpha CD +
fluoresceine
fluoresceine
Fig. 5.24: 1H NMR spectra of ? CD and fluoresceine in D2O solution.
This indicates that the fluoresceine molecule interacts not only with the protons inside the
cavity, but also with the protons at the outer surface of the torus. Thus, in the case of this
drug external complexation occurs as well. Fluoresceine protons were significantly
shifted and also some new peaks appeared. These results confirmed formation of
fluoresceine-CD complexes.
The similar analysis is repeated with ? and ? cyclodextrin. Both flucloxacilline and
fluoresceine exhibit the strongest changes of the 1H NMR spectrum with ?-CD, then with
?-CD and the spectrum changed least for the complexation with ?-CD. This can be
explained by deeper immersion of drugs in the wider cavity of ? and ? cyclodextrin.
Proxyphylline does not build inclusion complexes with cyclodextrins.
The 2D NOESY technique was also applied to confirm complexation between
host and guest. For all experiments the mixing time was chosen to be 2s. Fig. 5.25 shows
the  2D  NOESY  spectrum  of  the  mixture  of ?-CD and fluoresceine in D2O.  Beside  the
intramolecular interactions, intermolecular cross-peaks were observed between aromatic
protons of both drug molecules and H-3 and H-5 protons of ?, ?, and ? CD.
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Fig. 5.25: 2D NOESY spectrum of ?-CD and fluoresceine in D2O
Cross-peaks between aromatic protons of fluoresceine and external protons (H-2, H-4) of
cyclodextrins also confirm that this drug molecule interacts with the protons at the outer
surface of the CD torus.
The PFGE NMR technique was employed to study drug and cyclodextrin
diffusion  in  D2O  solution.  The  results  are  shown  in  Table  5.6.  Drug  and  cyclodextrin
diffusion coefficients were lower in comparison with the diffusion coefficients of the free
drug in water and the free CD in water, respectively. It can be seen that the drug diffusion
in the complex is faster than the CD diffusion in the complex. This must mean that the
drug molecule exchanges fast between a state where it is bound in the complex and a
state where it is free in the water solution. This is possible because these drugs are water
soluble. The average diffusion coefficient of the complexed drug is then higher than that
of cyclodextrin. The more time the drug spends in the complex, the smaller will be the
difference between drug and CD diffusion coefficients. These changes of drug diffusion
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in the presence of cyclodextrins served also as an evidence of formation of inclusion
complex.
Table 5.6 Self-diffusion coefficients (in 10-10 m2s-1) of drug-cyclodextrin complexes
Drug + CD in water
system CD water
drugD (3.6) waterCDD
?-CD 2.9 2.4
?-CD 3.2 2.4flucloxacilline
?-CD 2.2 2.0
Drug + CD in water
system CD water
drugD (3.2) waterCDD
?-CD 2.8 2.3
?-CD 2.9 2.4fluoresceine
?-CD 2.1 1.9
Drug + CD in water
system CD
water
drugD waterCDD
ibuprofen ?-CD 2.8 2.7
For comparison the diffusion coefficients in the absence of CD are given in the headers in parantheses
5.6.1 Complexation of a water insoluble drug
All cases presented so far concern water soluble drug molecules. A very
important application of cyclodextrins is as solubilizing agents to increase the water
solubility and bioavailability of water insoluble drugs. This property of cyclodextrins is
demonstrated on the example of ibuprofen which has a poor solubility in water. A
formulation of 20 mg ibuprofen with 18 mg ? cyclodextrin  in  D2O has been prepared
(drug:CD molar ratio ? 6:1). After filtration a clear solution is obtained and its NMR
spectrum recorded. Fig. 5.26 presents the proton NMR spectra of ?-CD  alone  and  the
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complex solution of ?-CD and ibuprofen. After addition of cyclodextrin the drug lines are
observed in the spectrum in D2O solution which already shows that the drug solubility is
enhanced.
1.61.82.02.22.42.62.83.03.23.43.63.84.04.2 ppm
beta CD
beta CD +
ibuprofen
Fig. 5.26: 1H NMR spectra of ?-CD and ibuprofen in D2O solution
Fig. 5.26 clearly shows that the inner protons of cyclodextrins are upfield shifted in the
presence of the drug. This implies that the drug is located in the hydrophobic cavity of
cyclodextrin. Although ibuprofen is a water insoluble drug, it is able to form an inclusion
complex with ? cyclodextrin in water. The diffusion of ibuprofen in the complex solution
is measured with the PFGE method. The results are shown in the Table 5.6. In this case
the drug and CD diffusivity in the complex are approximately equal. Because of the very
low water solubility this drug spends almost 100% of the time in the complex with ?-CD
and that causes their diffusion coefficients to be the same. Encapsulation of ibuprofen by
cyclodextrin opens a new possibility for CD applications for increasing the solubility of
water insoluble drug in hydrogels.
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5.7 Inclusion complexes in swollen polymer networks
The property of cyclodextrins to build inclusion complexes with different drug
molecules led to the idea that the effective molecular mass of the drug thus will be
increased. The hypothesis being investigated is that since the drug-CD complex will have
a  higher  molecular  mass  than  the  drug  molecule  alone,  the  drug-CD  complex  once
absorbed by the gel should exhibit a slower diffusion than a non-complexed drug
molecule in the gel. For drug delivery this can be desirable and we therefore investigated
the behavior of CD-complexed drugs in cross-linked polymer matrices, both for water
soluble and water insoluble drugs.
5.7.1 Complexes of water soluble drugs in hydrogel
The investigated systems were composed of water soluble drug (flucloxacilline
and fluoresceine), cyclodextrin (?, ? and ?) and cross-linked polymer (PEGDA 2000 and
PEGDA  450).  The  networks  were  let  to  swell  in  drug-CD  complex  solutions.  The  aim
was to find out the effect of cyclodextrins on drug diffusion and therefore on drug release
from a cross-linked polymer matrix.
The 1H NMR spectra of a mixture PEGDA/CD/drug/D2O (four-component system) are
presented in Fig. 5.27 and 5.28. These figures show the effect on the proton spectra of
flucloxacilline when ? cyclodextrin is added to the PEGDA 2000 hydrogel. Figures 5.27a
and 5.27c present the same spectra as in figures 5.9a and 5.9c, i.e. flucloxacilline in water
and flucloxacilline in swollen PEGDA 2000 matrix, respectively. Comparison of the
spectra 5.27b and 5.27d reveals that the peaks of the drug in the water phase of the two-
phase  systems  after  addition  of  cyclodextrin  are  at  the  same  chemical  shift  as  the
corresponding resonances in the drug-CD complex solution. This indicates that the drug
molecules  which  are  present  in  the  water  phase  in  the  four-component  mixture  are
complexed with CD molecules. Upon comparison of the spectra in Fig. 5.27c (drug +
PEGDA 2000) and in Fig. 5.27d (drug + CD + PEGDA 2000), the same pattern is
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observed: each drug multiplet representing the drug in the water phase (Fig. 5.27c) or the
drug-CD complex in the water phase (Fig. 5.27 d) is accompanied by a broadened line at
the low field side.
Fig. 5.27: The aromatic region of the 1H spectrum of flucloxacilline in water (a), in water
plus ?-CD (b), in PEGDA 2000 plus water (c), and in the mixture water, ?-CD and
PEGDA 2000 (d).
It can be clearly seen that the corresponding broad lines in Fig. 5.27c and 5.27d do not
have the same chemical shift. While chemical shift of the drug in the gel phase of swollen
PEGDA matrix is affected by the presence of cyclodextrin, we conclude that the drug-CD
complex in the case of Fig. 5.27d is (at least partly) absorbed in the PEGDA 2000 gel
network. The complex is therefore found both in the water and in the gel phase and it is
in a similar way as the drug alone, partitioned between the two phases of the four-
component system.
In Fig. 5.28c and 5.28d the ?-CD lines in the 2.6-4.1 ppm spectral region are presented,
in addition to the broad polymer line and a flucloxacilline CH3 resonance. The figure
shows  that  the  widths  of  the  ?-CD  resonances  are  affected  by  the  presence  of  the
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network. The chemical shift of cyclodextrin resonances in the presence of polymer
remained unchanged with respect to cyclodextrin resonances in D2O solution. This is
different for the drug, which has in the gel phase a chemical shift that differs from the
drug shifts in the gel in the absence of CD. Therefore, the drug-CD complex is located in
the gel, but the CD resonances are not affected by the gel. We will explain this in the next
chapter. The fact that the resonances of flucloxacilline in the PEGDA network change
when cyclodextrin is added is also shown in this figure by the high-field flucloxacilline
line.
Fig. 5.28: The 2.6-4.1 ppm region of the 1H spectrum of flucloxacilline in water (a), of
the mixture flucloxacilline, PEGDA 2000 plus water (b), of flucloxacilline in water plus
?-CD (c), and of mixture flucloxacilline, water, ?-CD, and PEGDA 2000 (d).
In  the  same  way  as  before  the  self-diffusion  coefficients  of  drug  and  CD
molecules in the PEGDA matrix can be determined. PFGE NMR diffusion measurements
show that in the PEGDA 2000 matrix, ? and ? cyclodextrins have two components with
different diffusivities. The component with higher diffusion coefficient corresponds to
the complexed CD molecules in the water phase and the slower component corresponds
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to  the  cyclodextrins  in  the  hydrogel  phase  of  a  swollen  polymer.  In  the  systems  with
PEGDA 450 polymer only the fast cyclodextrin component is found. This can be
explained by the small mesh size of the PEGDA 450 matrix which disables CD
molecules  to  come  into  the  gel  phase.  The  drug-CD  complexes  due  to  their  molecular
size are not in all drug/cyclodextrin/PEGDA combinations absorbed by the gel. PEGDA
450 does not absorb any of the complexes. Also complexes with ?-CD are not absorbed
by the PEGDA 2000 gel. The results of diffusion measurements in the swollen matrices
are shown in the Table 5.7. Only those drug/CD/PEGDA combinations are shown for
which the complexes are partitioned between the two phases.
Table 5.7 Drug self-diffusion coefficients (in 10-10 m2s-1) in the presence of cyclodextrins
in the water phase and in the gel phase of PEGDA 2000.
system CD waterdrugD
gel
drugD
no CD 3.6 0.4
with ?-CD 2.9 0.5Flucloxacilline
with ?-CD 3.1 0.6
system CD waterdrugD
gel
drugD
no CD 3.2 0.5
with ?-CDfluoresceine
with ?-CD 2.8 0.5
In the case when the polymer matrix is swollen in drug complex solution with ?
cyclodextrin an interesting feature is observed. Fig. 5.29 shows the proton NMR spectra
of PEGDA 2000 matrix, in one case swollen in flucloxacilline solution and in the other
case swollen in the solution of ?-CD/flucloxacilline complex. From the figure it can be
seen that in the presence of ?-CD the drug resonances in the gel phase become
significantly smaller and hard to observe. Because of its big molecular size the drug
complex with ? cyclodextrin can not be absorbed by the PEGDA 2000 gel. The chemical
shift of the drug in the gel did not change by addition of cyclodextrin, which confirmed
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that in this case complexes are not present in the hydrogel. The drug resonances from the
water phase, as expected, are shifted due to complexation with ?-CD.
7.37.47.57.67.77.87.9 ppm
flucloxacilline
in PEGDA 2000
flucloxacilline/gamma CD
in PEGDA 2000
Fig. 5.29: Comparison of the 1H NMR spectra of PEGDA 2000 matrix swollen in
flucloxacilline solution and in flucloxacilline-gamma CD complex solution.
Diffusion measurements in water for this combination of drug and cyclodextrin in the
complex  (Table  5.6)  have  shown  that  drug  and  CD  diffusion  coefficients  do  not  differ
much. That means that the drug residence time in the complex with ? cyclodextrin is
much longer than in the complex with ? or ? cyclodextrin. Because the drugs are for most
of the time complexed in the gamma-CD complex and the complex is not taken up by the
gel, much less amount of the drug is present in the gel phase. That explains the significant
decrease of intensity of drug population in the gel in the presence of gamma cyclodextrin.
It was expected that the diffusion of a drug in a gel would slow down when the
drug complexes with a host molecule, because of the bigger mass and size of the
complex.  However,  inspection  of  Table  5.7  shows  that  this  is  not  the  case.  In  order  to
conclude what happens in the presence of cyclodextrins, the relative diffusion
coefficients of flucloxacilline are calculated with and without CDs and presented versus
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the polymer mesh size (Fig. 5.30). When the complex is not present in the hydrogel, the
drug diffusion remained unchanged as for the PEGDA 450 polymer.
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Fig. 5.30: Dependence of the relative flucloxacilline diffusion coefficients in the presence
of cyclodextrins on the polymer mesh size. The temperature averaged values are shown.
When the complexes are partitioned between the two phases, in some cases drug
diffusion is not significantly affected by cyclodextrins, but in some cases drug diffusion
in  the  gel  was  even  faster  than  without  complexation.  The  explanation  for  this  kind  of
behavior will be provided in Chapter 6, where the models for diffusion in the gel are
presented.
5.7.2 Complex of water insoluble drug in hydrogel
The ability of cyclodextrins to complex water insoluble drug led to the idea that in
this way a solution can be provided for introduction of drug molecules with poor water
solubility into the hydrogel. Indeed, the complexation with ? cyclodextrin enabled to
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study the behavior of practically water insoluble ibuprofen in the swollen PEGDA 2000
network. The matrix was swollen in a D2O solution of the drug complexed with ?-CD.
The proton NMR spectra shown in Fig. 5.31 present the complexation of ibuprofen with
?-CD in D2O (Fig. 5.31a) and the behavior of the complex in the polymer network (Fig.
5.31b).
Fig. 5.31: The aromatic region of the 1H spectrum of ibuprofen in the complex with ?-CD
in D2O (a) and in the complex with ?-CD in the swollen PEGDA 2000 matrix
In figure 5.31b it can be observed that beside the (broadened) resonances corresponding
to the drug-CD complex in the water phase there are additional peaks, similarly as for the
water soluble drugs. They arise from the drug population which is in the complexed form
present in the hydrogel. The CD complexes of ibuprofen are also partitioned between the
water and the gel phase.
Diffusion measurements on ibuprofen have shown that two components with different
diffusivities exist. The faster component represents the drug population in the complex
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with ?-CD in the water phase and its diffusion coefficients is smD waterdrug /1061.2 210??? .
The second component represents ibuprofen population in the gel phase with the
diffusion coefficient smD geldrug /1047.0
210??? . The presence of the drug-CD complex in
the gel creates the possibility to control the ibuprofen diffusion and the release of the
drug from the gel. Also the chemical shift of ibuprofen is affected by the gel, which
means that the drug is not 100% of the time bound to the CD.
Encapsulation by cyclodextrins opens a possibility to increase the solubility of insoluble
drugs in hydrogel drug carriers. This is very important for practical applications because
many important therapeutic drug molecules are poorly soluble in water. Just as in the
case of soluble drugs, by changing the cross-link density of the polymer matrix the
release rate from this matrix can be tuned. Such formulations could bring improvements
in the delivery of drugs.
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behavior of a drug in a gel matrix
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In this section a model describing the drug mobility in the gel and the drug-matrix
interaction is presented. The proposed model is primarily based on two sets of
experimental data: chemical shift and self-diffusion data. Also, an explanation for the
values of activation energies as well as for the drug interaction with the matrix in the
presence of cyclodextrins is provided.
6.1 A model for the drug-matrix interaction
Various models for the description of diffusion of small molecules in polymer
gels have been developed as explained in the Section 2.2.233. In lattice models the
diffusing molecule jumps between unoccupied lattice sites. The lattice sites which are
occupied by the polymer chains represent obstructions for the drug diffusion and are not
available for the diffusing molecules. Then, according to Mackie and Meares35, the
diffusion coefficient of a (small) molecule in a gel is a function of the volume fraction ?2
occupied by the polymer in the gel (see eq. 2.32).
Higher cross-linked polymer networks absorb less water and thus the polymer volume
fraction,  ?2, becomes larger. The polymer volume fraction in the gel ?2 has been
estimated for the three networks studied here, using the swelling factors reported in the
previous section. The value of ((1-?2)/(1+?2))2 (eq. 2.32) is shown in the last column of
Table 5.4. Comparison of this lattice model factor with the experimental diffusion
coefficients shows the expected trend, the larger the volume fraction ?2, the smaller the
diffusion  coefficients  of  the  drugs  and  of  water  molecules.  However,  this  lattice  model
description can not be entirely correct because it predicts for the same network an equal
decrease of the diffusion coefficient for drug molecules and for water, which is clearly
not the case (Tab. 5.4). Also we know from the chemical shifts waterdrug
gel
drug ?? ? of Table 5.2
that the drug molecules (and water) must interact in some way with the network. In all
lattice models the interaction between the diffusing molecule and the polymer matrix is
described as between hard spheres.
The model proposed here is completely analogous to the ligand-macromolecule
situation encountered so often for biomacromolecules84. It assumes that in the hydrogel
phase the drug molecules are on average for a certain fraction of the time ? “bound” to
Models describing the behavior of a drug in a gel matrix
121
the polymer network and immobilized in the bound state. For the rest of the time drug
molecules diffuse more or less freely in the water of the hydrogel phase, although
hindered by the fact that part of the space in the gel is taken up by the polymer chains
(Fig. 6.1).
Fig. 6.1: Schematic representation of the drug diffusion model with two separated phases:
(left) the hydrogel phase, (right) the water phase. The drug molecules are shown as
rounded rectangles. In the gel phase the drug and water molecules (not shown) both
exchange between a “bound” and a “free” state.
The meaning of “bound” should not be taken too literally. The model simply assumes
that the gel water volume can be divided in a volume in which the drug molecule does
not interact with the polymer and a volume in which the drug is under the influence of the
polymer chains. The exchange between these two states of the solute molecules must be
fast on the NMR time scale because one NMR signal and one diffusion coefficient for the
drug population in the hydrogel phase is observed. The self-diffusion coefficient and
chemical shift of the drug molecule in the hydrogel are then weighed averages of two
diffusion coefficients, respectively, two chemical shifts:
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? ? freedrugbounddruggeldrug DDD ????? ?? 1                                            (6.2)
? ? freedrugbounddruggeldrug ????? ????? 1                                            (6.3)
where  ? represents  the  fraction  of  the  time  (0<?<1)  the  drug  molecule  is  bound  to  the
network, bounddrugD and
free
drugD  the drug diffusion coefficients of the drug in the bound state
and moving in the gel water, respectively. In the same way bounddrug? and freedrug?  are defined.
The  two  equations  (6.2)  and  (6.3)  can  be  solved  for  ? and bounddrug? ,  if  we  make  the
following logical assumptions:
(a) 0?bounddrugD  (the drug is immobilized during the time it is bound to the network)
(b) ? ? ? ?? ?222 1/1 ?? ???? waterdrugfreedrug DD  (due to obstruction by the network the diffusion is
slower than in water, eq. 6.1)
(c) waterdrug
free
drug ?? ?
The values for waterdrugD ,
gel
drugD , and
water
drug
gel
drug ?? ? were measured. The results of the
calculations are shown in Table 6.1. The parameter ? is found to be practically
independent of the temperature for the investigated temperature range (vide infra) but
clearly increases with the network density. In the PEGDA 450 matrix, ? approaches 1 for
all three drugs. Unfortunately the freedrug
bound
drug ?? ?  values can not be compared between
different drugs, therefore from these data it can not be concluded that flucloxacilline
interacts stronger with the network than proxyphylline.
It should be emphasized here that ?, the fraction of the time the drug molecule is bound to
the polymer network, mainly depends on the amount of water absorbed by the hydrogel
phase. The larger the amount of hydrogel water, the larger the water volume in which the
drug moves independent of the network chains and the smaller the ?. Therefore ?
increases  with  the  cross-link  density  of  the  network.  When  ? only  depends  on  the
swelling factor, this also explains why ? is practically independent of the temperature
over the temperature range 12-37 0C for all investigated drug-polymer combinations. The
Models describing the behavior of a drug in a gel matrix
123
swelling curve in the phase diagram for such systems (see figure 2.7) is almost parallel to
the temperature axis27.
Table 6.1 Experimental and calculated parameters for the exchange model of drug
binding to the matrix; for all three drugs chemical shift values refer to aromatic protons.
System free
drug
gel
drug ?? ?  in ppm
from experiment
? free
drug
bound
drug ?? ?  in ppm
calculated from eq.(6.3)
Proxyphylline
PEGDA 4000 0.020 0.30 0.067
PEGDA 2000 0.033 0.51 0.065
PEGDA 450 0.040 0.77 0.052
Fluoresceine
PEGDA 4000 0.081 0.30 0.27
PEGDA 2000 0.132 0.66 0.20
PEGDA 450 0.166 0.92 0.18
Flucloxacilline
PEGDA 4000 0.046 0.40 0.11
PEGDA 2000 0.070 0.81 0.09
PEGDA 450 0.101 0.94 0.11
For the highest cross-link density, in sample PEGDA 450 with approximate mesh size of
14 Å, the drug molecules can be considered to be almost always within the water volume
near the network chains. It should be realized however, that the relatively narrow line
width (compared to the “rigid” line width) of the NMR lines of the drug in the gel shows
that in the gel the drug molecules are still free to rotate, even in the highest cross-linked
system, PEGDA 450. The interaction between drug and polymer network must be very
weak, as is also shown by the value of freedrug
bound
drug ?? ?  in Table 6.1, which is of the order of
0.1 ppm only. The drug molecules must be bound to the polymer by weak Van der Waals
interactions.
6.2 Activation energies
The  activation  energies  for  diffusion  of  water  and  of  drugs  are  all  of  the  same
order of magnitude (15-20 kJ/mol), both for the diffusion in the hydrogel phase as for the
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diffusion in water phase. Their values are comparable to the hydrogen bonding energy of
water. It seems that the barrier for diffusion for a molecule in water-rich systems is
mainly determined by the interaction with water molecules. The similar conclusion was
reached by Gao and Fagerness90 for drug diffusion in hydroxypropyl methylcellulose
gels.
The fact that the activation energies for the drug diffusion in the gel phase are so close to
those of the drug in the water phase can be explained with equation 6.2. Taking into
account that we find that ? is practically temperature independent (steep swelling curve in
the phase diagram of fig. 2.7), the temperature dependence of the drug diffusivity in the
gel is determined solely by the dependence of the diffusivity of the drug in the water.
This explains also the independence of the activation energy on the polymer cross-link
density.
6.3 Extension of the model in the presence of cyclodextrin
It was expected that the diffusion of a drug in a gel would slow down when the
drug complexes with a host molecule, because of the bigger mass and size of the
complex. Quaglia et al.91, for instance, have found that complexation of nicardipine with
?-CD decreases the drug diffusivity in a cross-linked PEG matrix. Inspection of Table 5.7
shows that in our case the complexation with cyclodextrins does not slow down the drug
diffusion in the gel. For instance, for flucloxacilline 1210104.0 ???? smD geldrug  in the
absence of CD and 1210105.0 ???? smD geldrug with ?-CD.
This surprising result can be explained by extending our model. It was mentioned in
Chapter 5 that the CD resonances do not change when the polymer swells in the solution
of a drug-CD complex. On the other hand, the drug resonances in the gel are affected by
the presence of cyclodextrins which means that the drug-CD complex is located in the gel
phase.  That  is  also  confirmed  by  the  existence  of  two  CD  fractions  with  different
diffusivities. Therefore, the cyclodextrins are present in the hydrogel in the complexed
form, but they themselves do not interact with the polymer matrix and that is why their
resonances are not shifted.
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We can now extend our previous model in that we assume that flucloxacilline in the
PEGDA gel network can exchange between three sites, flucloxacilline free in the gel
water, flucloxacilline in the complex with ?-CD in the gel water and flucloxacilline
bound to the network chains. The flucloxacilline self-diffusion coefficient can then be
written as:
? ? freedrugcomplexdrugbounddruggeldrug DDDD ???????? ???? 1                                (6.4)
where  ? and  ? are  the  fractions  of  time  the  drug  spends  in  the  bound  state  and  in  the
complex, respectively. This equation contains too many unknowns to solve for
coefficients ? and ?, as we did before with equation 6.2. But it is easy to see from eq. 6.4
that depending on the values of ? and ?, there can be situations where complexation with
a host molecule even increases the drug diffusion rate, for instance when due to presence
of the diffusing complex the fraction of the time the drug is “bound” to the polymer
(coefficient ?) is decreased. The behavior of the drug when drug-CD complex is present
in the gel phase is shown in Fig. 6.2. Instead of being immobilized by the network for a
sizable fraction of the time the drug is then able to move for a larger fraction of the time.
Complexation  of  a  drug  molecule  to  CD  therefore  does  not  necessarily  slow  down  the
drug diffusion in the matrix.
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gel phase
“bound”
?
“free”
1-???
“complex”
?
Fig. 6.2: Schematic representation of the drug diffusion model in the presence of
cyclodextrins. The gel phase is shown with drug molecules presented as rounded
rectangles. In the gel phase the drug molecules exchange between three sites.
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7.1 Introduction
Amiodarone is a very important drug molecule for the treatment of heart diseases
such as arrhythmia and hypertension. Due to its poor solubility in water it is very difficult
to make a water-based delivery system with a sufficient concentration of this drug. It is of
great importance to overcome these limitations and to increase the availability of
amiodarone to the human body. Our idea was to increase the water solubility of this drug
by complexation  to  cyclodextrin.  In  that  way the  water  solubility  of  the  drug  would  be
increased. Because drug-CD complexes can be absorbed by PEGDA matrices (as shown
previously) in this way amiodarone would be introduced into a hydrogel drug delivery
system. By changing the cross-link density of the polymer matrix, it would be possible to
control the drug diffusion in the gel and to tune the drug release rate from the matrix. The
same procedure was applied to the water insoluble drug ibuprofen and allowed to
introduce ibuprofen in the PEGDA hydrogel (Chapter 5).
However during preparation of the amiodarone complex with ?-cyclodextrin, a
completely different behavior of this drug is observed than in the case of ibuprofen.
When mixing certain amounts of amiodarone and ?-CD at room temperature it was found
that the viscosity of the solution is significantly increased, as can visually be detected
from the mixture in the glass tube. The drug-CD mixture (in the absence of the polymer
matrix) exhibits a behavior which seems to be not liquid-like. This striking feature of the
amiodarone/?-CD formulation has driven us to further investigate this system.
7.2 Experimental results
When  the  proton  NMR  spectrum  of  the  amiodarone/?-CD  mixture  in  water  is
measured at room temperature (Fig. 7.1), it can be observed that the drug lines of the
water insoluble amiodarone are present in the spectrum which shows that the drug
solubility in the water has been increased via complexation with CD. Otherwise the drug
resonances would not be detectable. Inspection of the spectrum also reveals that the CD
lines (proton lines in the range between 3-4.5 ppm as well as the OH group of
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cyclodextrin at ca 5.1 ppm) become strongly broadened. The narrow lines on the top of
the broad CD lines arise from overlapping drug lines in the same spectral region.
Fig. 7.1: The proton NMR spectra of ?-CD in D2O (a) and amiodarone/?-CD
mixture in D2O (b).
Fig. 7.2 shows the 1H  NMR  spectra  of  the  amiodarone/?-CD  system  at  different
temperatures in the temperature range between 25 and 75 0C. With increasing
temperature both the broad lines of cyclodextrin and the drug lines become narrower.
Above ca 45 0C the lines are as narrow as from a solution of small molecules. Also it was
observed that this narrowing of the lines with increasing temperature is reversible. When
the sample is cooled down to the room temperature, the resonances get broad again.
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Fig. 7.2: Temperature dependence of the 1H NMR spectrum of the amiodarone/?-
CD mixture in D2O. The temperature was varied from 25 to 75 0C.
When the spectrum of the amiodarone and ?-CD mixture is compared to the spectrum of
?-CD alone at temperatures above 45 0C, it can be clearly seen that the CD lines in the
mixture are significantly shifted upfield relative to the solution of the CD alone in water
(Fig. 7.3). That means that although the sample is liquid-like at 65 0C, the amiodarone
and the CD still form an inclusion complex.
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Integration of the drug lines as well as the CD lines at different temperatures shows that
the intensities of both the drug and CD lines increase significantly with the temperature in
the range 25-70 0C. This means that at room temperature part of the drug and CD is NMR
invisible. Therefore there must be at least two fractions of amiodarone/CD complexes.
One fraction at room temperature is so rigid, that it can not be observed by our high
resolution (“liquid” NMR) experiment. The other fraction with broad CD lines also has a
limited rotational mobility but not so much that it escapes NMR detection.
The self-diffusion measurements at room temperature, when the CD lines of the
fraction with limited mobility are broad, reveal that the diffusion of the visible drug
fraction is extremely slow. The diffusion coefficient of amiodarone at room temperature
is 9.55?10-12 m2s-1, which is even slower than the diffusion of the biggest water soluble
drug (flucloxacilline) in the highest cross-linked polymer network (PEGDA 450). The
diffusion of the invisible drug fraction can not be determined and is expected to be even
slower.
Fig.  7.3  shows the 1H NMR spectra  of  the  drug  and  ?-CD mixture  for  different
molar fractions of the amiodarone in the system. By increasing the drug concentration in
the amiodarone/?-CD mixture, starting from zero concentration, the cyclodextrin lines
become broader up to the point where the molar ratio of the drug and CD is between 1:2
and 1:1. Then the CD line widths remain constant.
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Fig. 7.3: Changes of the 1H NMR spectrum of the amiodarone/?-CD formulation with
increasing the drug:CD molar ratio in the beginning mixture.
The aromatic drug lines shift to higher field up to this point. Measurement of diffusion
for different drug concentrations shows that the drug diffusion rate decreases with
increasing  amount  of  the  drug.  From the  concentration  ratio,  where  the  drug:CD molar
ratio  is  between  1:2  an  1:1,  on,  the  drug  diffusion  remains  constant.  These  changes  of
drug diffusion together with the changes of the chemical shift of drug aromatic protons
are shown in Fig. 7.4.
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Fig. 7.4: Changes of the chemical shift of three drug aromatic protons and the
drug diffusion coefficient with increasing molar fraction of amiodarone in the system.
The assignment of the different drug protons is given in the Appendix 9.4.
In order to get better insight into this phenomenon, we investigated how this
mixture interacts with polarized light in an optical microscope. Fig. 7.5 shows the
microscope images of the sample at different temperatures. The amplification factor was
112. Optical microscopy with polarized light shows that the sample is locally
birefringent. At room temperature structures are observed which seem like bundles of
fibers. That means that in the mixture locally ordered structures (ordered domains) must
exist. By increasing the temperature, the fraction of these ordered domains is decreasing
and above 45 0C the sample does not show the light polarization effects anymore.
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Fig. 7.5: Optical microscopy with polarization light. Images of the amiodarone/?-
CD sample at different temperatures.
It was found also here that after cooling down to the room temperature the ordered
structures are again observable.
Intrigued by the presence of liquid-NMR-unobservable drug and CD molecules in
the mixture at room temperature a solid state NMR method is applied to attempt to
directly detect those rigid components of the amiodarone/?-CD mixture. Fig. 7.6 shows
the 13C CPMAS spectra of solid ?-cyclodextrin and the formulation of amiodarone/?-CD.
In the mixture the resonances of ?-cyclodextrin are clearly observed (60-120 ppm)
showing that cyclodextrin is part of the rigid domains in the sample. The drug molecules
are hardly observed by the CPMAS method which shows that they must be relatively
mobile.
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Fig. 7.6: 13C CPMAS spectra of the ?-cyclodextrin powder and the amiodarone/?-
CD mixture (drug/CD molar ratio in the initial mixture is 2:1, T=28 0C).
By increasing the temperature the intensity of the ?-CD resonances slowly decreases. Fig.
7.7 presents CPMAS spectra of the sample at different temperatures. The supramolecular
structures gradually disappear when the temperature is increasing up to 70 0C.
A novel drug delivery system for the drug amiodarone without polymer matrix
136
Fig. 7.7: 13C CPMAS spectra of the amiodarone/?-CD mixture at different
temperatures in the range from 28 to 65 C.
A very interesting feature is observed when to the amiodarone/?-CD formulation
another drug is added which possesses the property to build an inclusion compound with
?-cyclodextrin. For example, by addition of flucloxacilline the previously high-viscosity
solution becomes very fast a low viscosity liquid. The broad CD lines become narrow
and the amiodarone lines can not be observed anymore in the NMR spectrum (Fig. 7.8).
The same effect occurs when fluoresceine, which is also able to form inclusion complex
with ?-CD, is added. These drugs compete for the cyclodextrin binding and apparently
are able to destroy the existing structure with amiodarone and ?-cyclodextrin.
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Fig. 7.8: 1H NMR spectra of the amiodarone/?-CD mixture (a), the same mixture after
addition of flucloxacilline (b) and the flucloxacilline/?-CD complex solution (c).
For a structural elucidation valuable information can be obtained by modeling the
interaction between amiodarone and ?-cyclodextrin. The modeling was performed by Dr.
B. Coussens from DSM Research. Computations are done using software programs from
Accelrys. Dynamics and energy minimizations are performed with MS.Forcite using the
COMPASS forcefield. Graphical displays are generated with Materials Studio. The
results  are  shown in  the  Fig.  7.9.  The  figure  is  a  minimized  structure  (minimal  energy)
using modeling and it shows three cone-shaped CD molecules and two amiodarone
molecules. Each drug molecule interacts with two cyclodextrins. The figure indicates that
by continuing this pattern, the formation of a chain of CD molecules, held together by
amiodarone molecules, seems possible.
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Fig. 7.9: Optimized structure by molecular modeling of the amidarone-?-CD interactions.
7.3 Discussion
In this chapter we showed that by mixing amiodarone and ?-cyclodextrin at room
temperature at a molar ratio somewhere between 1:2 and 1:1 a highly viscous liquid is
obtained.
The NMR experiments show that:
a. a fraction of the drug and CD molecules in the mixture is at room temperature
NMR invisible by liquid NMR;
b. the CD molecules in that fraction are detectable by solid state NMR;
c. the diffusion of the drug molecules, measured via liquid NMR techniques, is
even  slower  than  that  of  the  largest  drug  molecule  in  the  most  cross-linked
PEGDA matrix;
d. by increasing the temperature the liquid-NMR-invisible fraction gradually
decreases till at 70 0C the rigid fraction has disappeared. At that temperature
amiodarone/CD complexes still exist;
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e. the optical polarized microscopy images show that the mixture at room
temperature is locally birefringent. This birefringence suddenly disappears at
45 0C.
Combining these observations one comes to the conclusion that at room temperature
large, rigid supramolecular structures must exist that are much larger than a drug/CD
complex. They give the mixture their high viscosity and contain the liquid-NMR-
invisible drug and CD fractions.
Akira Harada and coworkers found that ?-cyclodextrin can spontaneously be threaded on
a linear polyethylene glycol chain to form a crystalline supramolecular complex92. In this
assembly PEG penetrates the tunnel made of cyclodextrins and such a structure is called a
molecular necklace (Fig. 7.10). Later it was also shown that in the presence of linear
polymer chains cyclodextrins can act as cross-linking agents93.
Fig. 7.10: Formation of molecular necklace from cyclodextrins and linear polymer
chain94.
In  view  of  the  modeling  results  we  propose  a  similar  process  for  the
amiodarone/?-CD mixture. Here the amiodarone molecules must form the chain in the
necklace. Amiodarone is a relatively large drug molecule which is long and possesses
several interaction sites for interaction with cyclodextrin molecules. For this reason one
drug molecule is expected to penetrate two cyclodextrins. Continuing this pattern,
molecular  rods  are  formed,  similarly  as  in  the  case  of  the  polymer  and  cyclodextrin  in
A novel drug delivery system for the drug amiodarone without polymer matrix
140
Fig. 7.10. Even the formation of cross-links seems possible, turning the liquid mixture
into a gel.
The optical polarization experiments suggest that in addition the necklaces locally order
to oriented domains, crystalline or liquid-crystalline domains. In that case we locally
would have a physically cross-linked gel. The polarization effects are not homogeneous
for the whole sample, in other words the ordering is not homogeneous.
We tried to establish with NMR if this ordering was liquid-crystalline like. In that case
orientation effects could appear in a magnetic field when the domains would be free to
orient, resulting in splitting of NMR lines. Since this did not happen, the ordered
structures apparently are too rigid to allow orientation in a magnetic field.
Summarizing all experimental findings we propose that amiodarone and ?-cyclodextrin at
room temperature form a gel, consisting of chains of amiodarone-cyclodextrin. Physical
cross-linking of these chains occurs by ordered crystalline regions. In a rather narrow
temperature range, between 40 and 50 0C, the crystalline regions are dissolved (the
polarization effects disappear). At increasing temperature, between 25 and 70 0C, the
supramolecular structures (chains) gradually dissolve into individual drug/CD complexes.
The hydrogel formed by cyclodextrin and the drug represents a potential drug
delivery system for the release and delivery of this important anti-arrhythmic drug
amiodarone.  The  advantage  of  this  system  is  that  the  cross-linking  in  the  gel  is  of
physical nature which does not affect the drug molecule. Beside the drug the only
components of this supramolecular delivery system are cyclodextrins which are water
soluble, non-toxic and biocompatible. This novel hydrogel drug delivery system is
temperature sensitive at temperatures near the body temperature and in this way drug
diffusion rate can be controlled. The fact that addition of other cyclodextrin-complexing
molecules can disturb the gel makes this system very attractive for the targeted drug
delivery where it is often necessary to achieve a burst release of the drug at a certain site.
Also this gel can be injected through a needle which is for some applications more
attractive than implantable hydrogels.
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The aim of this work was to study the drug mobility and drug-matrix interaction
in a hydrogel drug delivery system.
As polymeric drug delivery systems cross-linked PEG-containing polymer gels
were used. With increasing cross-link density of the matrix the network mesh size
decreases and the polymer exhibits lower swelling (swelling factor decreases). This
affects the drug behavior in the gel. Different NMR methods provided information about
the drug mobility in the gel and drug-polymer interaction. 1H NMR spectroscopy was
employed for the determination of the direct drug-polymer interaction via the drug proton
chemical shifts, self-diffusion measurements for the study of translational mobility of
drug  molecules  and  water  in  the  network  and  T1 and  T2 measurements for the study of
drug rotational mobility. All experiments were performed on drug-polymer-water
systems that contain more water than the maximum amount the polymer network can
take up by swelling. Therefore the systems were composed of two phases: water phase
and gel phase. Under these conditions proton NMR spectra show that water soluble drugs
partition  between  the  gel  phase  and  the  water  phase.  For  the  drugs  in  the  gel  phase  a
model has been proposed in which the drug molecule exchanges fast between a state in
which the drug is “bound” to the polymer network and a state in which the drug molecule
is dissolved in the hydrogel water. This model and the experimental chemical shifts
provide a quantitative measure for the drug-network interaction. The differences in
chemical shift of protons of the drug bound to polymer and of the drug freely dissolved in
water, freedrug
bound
drug ?? ? , are very small, demonstrating the very weak drug-polymer
interaction (van der Waals type), even for the largest drug and the highest cross-link
density.
The drug self-diffusion and relaxation experiments show that the translational and
rotational diffusional mobility of drug molecules in the investigated polymer networks is
a complex function of the drug molecular mass and size and of the network cross-link
density.  When the  cross-link  density  of  the  network  increases,  the  diffusion  rate  of  the
drug molecules decreases. The translational diffusion is already hindered by the polymer
network when the mesh size of the network is still much larger than the drug molecular
size. On the other hand, the rotational mobility of the drug molecules is not very much
dependent on the network cross-link density, except for the largest drug in the most dense
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network, where the network mesh size approaches the drug molecular size. Under such
conditions the rotational motion of the drug molecules becomes very anisotropic, as
evidenced by the drug proton T2 relaxation studies.
It has been shown that the network cross-link density represents an important tuning
parameter in the polymeric drug delivery. It affects polymer morphology and surface
properties of these materials (as shown by AFM), swelling behavior, diffusional mobility
of the drug molecules in the gel and thereby the drug release rate.
Our study is also concerned with cyclodextrins, one of the most important
molecular drug carriers. Two of the water soluble drugs investigated here form host-guest
type inclusion complexes with cyclodextrins. It is found that the complexes also partition
between the water phase and the gel phase. In contrast to expectation, the complexation
of the drug to the CD does not necessarily slow down the drug diffusion in the gel
network. This is explained by extending the model used to describe the diffusion of the
drug alone in the network. When the drug-CD complexation is also described as an
equilibrium reaction, the drug self-diffusion rate will depend on the equilibrium constants
for the drug ? cyclodextrin and drug ? network equilibria. Combination of these
equilibrium constants exist for which the drug diffusivity increases by the presence of a
host molecule.
The  fact  that  water  insoluble  drugs  can  build  an  inclusion  complex  with
cyclodextrin is of great importance for the delivery of such drugs. By this means the
solubility of the drug is enhanced which enables the introduction of the drug into the
polymeric hydrogel as shown for the water insoluble drug ibuprofen. The drug
availability and the efficiency of delivery of water insoluble drugs can be thus
significantly improved.
Further in this work it was found that in the case of the water insoluble drug
amiodarone and ?-cyclodextrin the drug-CD complexation leads to large, rigid
supramolecular structures. We propose that the amiodarone molecules connect
cyclodextrins to form linear chains. Locally these linear chains can order and probably
form crystalline regions, which leads to a physically cross-linked gel. The properties of
this complex material are strongly temperature dependent. At ca 45 0C the ordered local
structures, and therefore the gel, disappear, while the supramolecular chain structures
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disappear gradually in the temperature range 25 to 70 0C. This finding is of great
importance for improvements in the delivery formulations of this important
antiarrhythmic drug.
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Chapter 9: Appendices
Appendices
146
9.1 1H NMR spectra of water soluble drugs in swollen matrices
Proxyphylline and fluoresceine exhibit the same behavior as flucloxacilline in
ternary drug/polymer/water systems. Figures 9.1 and 9.2 present the proton NMR spectra
of proxyphylline and fluoresceine in swollen PEGDA matrices of different cross-link
density, respectively.
Fig. 9.1: 1H NMR spectra of proxyphylline in water solution (a), in PEGDA 4000 (b), in
PEGDA 2000 (c), and in PEGDA 450 (d).
In both cases the spectra show the same pattern as in the case with flucloxacilline. Beside
the drug lines at the chemical shift for the drug in water, new lines appear, arising from
the drug population in the gel phase of the two-phase systems. The drug and water
molecules are partitioned between the water and the gel phase. At higher cross-link
densities the lines become broader and the chemical shift difference between the two
drug (or water) components increases.
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Fig. 9.2: 1H NMR spectra of fluoresceine in water solution (a), in PEGDA 4000 (b), in
PEGDA 2000 (c), and in PEGDA 450 (d).
9.2 Activation energies of water soluble drugs
Figures 9.3 and 9.4 represent the temperature dependence of diffusion of
proxyphylline and fluoresceine in both the water and hydrogel phase of swollen PEGDA
matrices  with  different  cross-link  densities.  Here  as  well,  the  activation  energies
determined  by  the  slope  of  the  curves,  do  not  change  with  the  cross-link  density  of  the
matrix. For a certain degree of cross-linking, activation energies do not differ for the
water and the hydrogel phase of the two-phase systems. It can be observed that the drug
diffusion  in  the  water  phase  of  PEGDA  4000  system  is  somewhat  slower  than  the
diffusion in the water phase of PEGDA 2000 and PEGDA 450 matrix. This is because for
the PEGDA 4000 matrix a slow exchange occurs between the drugs in the two phases of
the swollen polymer.
Appendices
148
Fig. 9.3: Arrhenius plots of ln(D) of proxyphylline versus the reciprocal of the
absolute temperature in different PEGDA matrices. The dashed lines represent the drug
diffusion in the water phase, the solid lines the diffusion in the gel phase.
Fig. 9.4: Arrhenius plots of ln(D) of proxyphylline versus the reciprocal of the
absolute temperature in different PEGDA matrices. The dashed lines represent the drug
diffusion in the water phase, the solid lines the diffusion in the gel phase.
Appendices
149
9.3 Structural assignment of cyclodextrin protons
Cyclodextrin protons can be classified as external and internal protons. Fig. 9.5
shows a structure of the glucose unit of a CD molecule with atom numbering.
Fig. 9.5: Glucose residue of a cyclodextrin molecule with atom numbering89
External  protons  (H-2,  H-4)  are  located  at  the  outer  surface  of  the  torus,  while  internal
protons (H-3, H-5) are placed in the internal hydrophobic cavity. Fig. 9.6 presents the 1H
NMR spectrum of ?-CD in water including the assignment for different cyclodextrin
protons.
3.53.63.73.83.94.04.14.2 ppm
H-3
H-5,6,6'
H-2
H-4
Fig. 9.6: CD spectral region of 1H NMR spectrum of ?-cyclodextrin in water
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If a guest molecule is at least partly included in the CD cavity it should affect the internal
protons of cyclodextrin and its corresponding resonances in the NMR spectrum will be
shifted.
9.4 Assigned molecular structure of amiodarone
The 2-dimensional molecular structure of the water insoluble drug amiodarone is
shown in Fig. 9.7 along with alphabetical assignment for different drug protons.
Fig. 9.7: Chemical structure of amiodarone with designated drug protons
The proton NMR spectrum of this drug in the mixture with ?-cyclodextrin is presented in
Fig. 9.8. The NMR signals of corresponding drug protons are also alphabetically
designated.
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Fig. 9.8: Assigned 1H NMR spectrum of amiodarone in the mixture with ?-CD.
9.5 List of abbreviations
1D                 one-dimensional
2D                 two-dimensional
3D                 three-dimensional
AFM             Atomic Force Microscopy
ATR FTIR    Attenuated Total Reflection Fourier Transform Infrared
CAS              Chemical Shift Anisotropy
CD                Cyclodextrin
CP                 Cross Polarization
CW                Continuous Wave
D                    Diffusion coefficient
DDS               Drug Delivery System
DP                  Degree of polymerization
Appendices
152
Ea                    Activation energy
FID                 Free Induction Decay
FT                   Fourier Transformation
?                     Planck’s constant divided by 2? (h/2?)
kb                    Boltzmann constant (1.381?10-23 J/K)
MAS               Magic Angle Spinning
Mc                   Average molecular weight between cross-links
NMR               Nuclear Magnetic Resonance
NOE                Nuclear Overhauser Effect
NOESY           Nuclear Overhauser Enhancement Spectroscopy
OEG                oligo(ethylene glycol)
PEG                 poly(ethylene glycol)
PEGDA           poly(ethylene glycol) diacrylate
PEO                 poly(ethylene oxide)
PFGE               Pulsed Field Gradient Echo
R                      Universal gas constant (8.314 J/mol?K)
STD                 Saturation Transfer Difference
TMS                Tetramethylsilane
UV                   Ultraviolet
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